|
OMIM |
Link |
Information gain |
01 |
|
RA
|
[NCBI]
|
0.00521616
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.00300569
|
|
|
small cell cancer of the lung
|
[NCBI]
|
0.00276271
|
|
|
iminoglycinuria
|
[NCBI]
|
0.00269978
|
|
|
SLE
|
[NCBI]
|
0.00261647
|
|
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
0.00199053
|
|
|
MTACR1
|
[NCBI]
|
0.00191306
|
|
|
hyperbilirubinemia, rotor type
|
[NCBI]
|
0.00147659
|
|
|
TSD
|
[NCBI]
|
0.00113711
|
|
|
thyroid hormonogenesis, genetic defect in, 4
|
[NCBI]
|
0.00111532
|
|
|
HBB
|
[NCBI]
|
0.00110217
|
|
|
HBFQTL2
|
[NCBI]
|
0.00091056
|
|
|
EFMR
|
[NCBI]
|
0.000844966
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
0.000773823
|
|
|
EGF
|
[NCBI]
|
0.000744863
|
|
|
adenosine triphosphatase deficiency, anemia due to
|
[NCBI]
|
0.000737705
|
|
|
urate-binding globulin, decrease in
|
[NCBI]
|
0.000737705
|
|
|
migraine with aura, susceptibility to, 9
|
[NCBI]
|
0.000737705
|
|
|
AN
|
[NCBI]
|
0.000737705
|
|
|
cataract, ataxia, short stature, and mental retardation
|
[NCBI]
|
0.000737705
|
|
|
salivary substance, clostridium botulinum type
|
[NCBI]
|
0.000737705
|
|
|
leukoencephalopathy with metaphyseal chondrodysplasia
|
[NCBI]
|
0.000737705
|
|
|
MRX42
|
[NCBI]
|
0.000737705
|
|
|
MCPH4
|
[NCBI]
|
0.000737705
|
|
|
xanthomatosis, susceptibility to
|
[NCBI]
|
0.000737705
|
|
|
hyperreninemic hypoaldosteronism, familial, 2
|
[NCBI]
|
0.000737705
|
|
|
BRCD1
|
[NCBI]
|
0.000695656
|
|
|
PHP
|
[NCBI]
|
0.000695656
|
|
|
alzheimer disease 5
|
[NCBI]
|
0.000640252
|
|
|
ST3
|
[NCBI]
|
0.000616828
|
|
|
MG
|
[NCBI]
|
0.000599535
|
|
|
TNF
|
[NCBI]
|
0.000530788
|
|
|
AD
|
[NCBI]
|
0.000510771
|
|
|
MDD
|
[NCBI]
|
0.000505096
|
|
|
VEGF
|
[NCBI]
|
0.000478922
|
|
|
stomatocytosis ii
|
[NCBI]
|
0.000476566
|
|
|
malaria, mild, susceptibility to
|
[NCBI]
|
0.000476566
|
|
|
HCFP2
|
[NCBI]
|
0.000476566
|
|
|
mannose 6-phosphate receptor recognition defect, lebanese type
|
[NCBI]
|
0.000476566
|
|
|
dibasicaminoaciduria i
|
[NCBI]
|
0.000476566
|
|
|
FTSD
|
[NCBI]
|
0.000476566
|
|
|
PDB4
|
[NCBI]
|
0.000476566
|
|
|
NNCI
|
[NCBI]
|
0.000476566
|
|
|
CMTX2
|
[NCBI]
|
0.000476566
|
|
|
breast cancer, 11-22 translocation associated
|
[NCBI]
|
0.000476566
|
|
|
ataxia, sensory, autosomal dominant
|
[NCBI]
|
0.000476566
|
|
|
alacrima, congenital
|
[NCBI]
|
0.000476566
|
|
|
tumor suppressor gene on chromosome 11
|
[NCBI]
|
0.000476566
|
|
|
holoprosencephaly
|
[NCBI]
|
0.000476271
|
|
|
ALD
|
[NCBI]
|
0.000455994
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.00045554
|
|
|
DMD
|
[NCBI]
|
0.000450884
|
|
|
OFC1
|
[NCBI]
|
0.000441595
|
|
|
AT
|
[NCBI]
|
0.000397581
|
|
|
MAFD2
|
[NCBI]
|
0.00038716
|
|
|
oculodentoosseous dysplasia, recessive
|
[NCBI]
|
0.00038054
|
|
|
MHAC
|
[NCBI]
|
0.00038054
|
|
|
faciodigitogenital syndrome, recessive
|
[NCBI]
|
0.00038054
|
|
|
CMTX3
|
[NCBI]
|
0.00038054
|
|
|
SPG15
|
[NCBI]
|
0.00038054
|
|
|
alzheimer disease 11
|
[NCBI]
|
0.00038054
|
|
|
pentosuria
|
[NCBI]
|
0.00038054
|
|
|
MCOPS4
|
[NCBI]
|
0.00038054
|
|
|
autoimmune thyroid disease, susceptibility to, 2
|
[NCBI]
|
0.00038054
|
|
|
restless legs syndrome, susceptibility to, 3
|
[NCBI]
|
0.00038054
|
|
|
gangliosidosis, gm2, type iii, or juvenile type
|
[NCBI]
|
0.00038054
|
|
|
HHC2
|
[NCBI]
|
0.00038054
|
|
|
PDR
|
[NCBI]
|
0.00038054
|
|
|
split-hand/foot malformation with sensorineural hearing loss
|
[NCBI]
|
0.00038054
|
|
|
CHDS8
|
[NCBI]
|
0.00038054
|
|
|
dermal ridges-off-the-end
|
[NCBI]
|
0.00038054
|
|
|
vacuolar neuromyopathy
|
[NCBI]
|
0.00038054
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
0.000374274
|
|
|
CF
|
[NCBI]
|
0.000366616
|
|
|
NGFB
|
[NCBI]
|
0.000357019
|
|
|
G6PD
|
[NCBI]
|
0.000346267
|
|
|
proteus syndrome
|
[NCBI]
|
0.000340238
|
|
|
BRCA2
|
[NCBI]
|
0.000331267
|
|
|
HMPS1
|
[NCBI]
|
0.000319611
|
|
|
camptodactyly with muscular hypoplasia, skeletal dysplasia, and abnormal palmar creases
|
[NCBI]
|
0.000319611
|
|
|
DYT6
|
[NCBI]
|
0.000319611
|
|
|
RP6
|
[NCBI]
|
0.000319611
|
|
|
cholestasis-lymphedema syndrome
|
[NCBI]
|
0.000319611
|
|
|
ichthyosis follicularis, atrichia, and photophobia syndrome
|
[NCBI]
|
0.000319611
|
|
|
HHC3
|
[NCBI]
|
0.000319611
|
|
|
MRX23
|
[NCBI]
|
0.000319611
|
|
|
prognathism, mandibular
|
[NCBI]
|
0.000319611
|
|
|
RP24
|
[NCBI]
|
0.000319611
|
|
|
PN
|
[NCBI]
|
0.000319611
|
|
|
CHDM
|
[NCBI]
|
0.000319611
|
|
|
NPY
|
[NCBI]
|
0.000314263
|
|
|
APRT
|
[NCBI]
|
0.000304714
|
|
|
HBFQTL1
|
[NCBI]
|
0.00028874
|
|
|
PWS
|
[NCBI]
|
0.00028493
|
|
|
PRL
|
[NCBI]
|
0.000278705
|
|
|
WT3
|
[NCBI]
|
0.000275351
|
|
|
DYT7
|
[NCBI]
|
0.000275351
|
|
|
anosmia, congenital
|
[NCBI]
|
0.000275351
|
|
|
PCNA
|
[NCBI]
|
0.000274462
|
|
|
KLK3
|
[NCBI]
|
0.000265913
|
|
|
HFE
|
[NCBI]
|
0.000255629
|
|
|
PTH
|
[NCBI]
|
0.000254604
|
|
|
CRC
|
[NCBI]
|
0.000244443
|
|
|
HCFP1
|
[NCBI]
|
0.000240909
|
|
|
RNANC
|
[NCBI]
|
0.000240909
|
|
|
peho syndrome
|
[NCBI]
|
0.000240909
|
|
|
EKD2
|
[NCBI]
|
0.000240909
|
|
|
SCAX1
|
[NCBI]
|
0.000240909
|
|
|
dysgnathia complex
|
[NCBI]
|
0.000240909
|
|
|
aniridia, cerebellar ataxia, and mental deficiency
|
[NCBI]
|
0.000240909
|
|
|
factor v deficiency
|
[NCBI]
|
0.00023135
|
|
|
FMF
|
[NCBI]
|
0.000231132
|
|
|
neuroblastoma
|
[NCBI]
|
0.000227052
|
|
|
GJB2
|
[NCBI]
|
0.000225913
|
|
|
ATRX
|
[NCBI]
|
0.000223711
|
|
|
CCK
|
[NCBI]
|
0.000222262
|
|
|
VIP
|
[NCBI]
|
0.000221856
|
|
|
CMM
|
[NCBI]
|
0.00022032
|
|
|
beta-aminoisobutyric acid, urinary excretion of
|
[NCBI]
|
0.000212954
|
|
|
BMND3
|
[NCBI]
|
0.000212954
|
|
|
spiegler-brooke syndrome
|
[NCBI]
|
0.000212954
|
|
|
schimmelpenning-feuerstein-mims syndrome
|
[NCBI]
|
0.000212954
|
|
|
CFEOM3
|
[NCBI]
|
0.000212954
|
|
|
gaucher disease, type i
|
[NCBI]
|
0.000211934
|
|
|
CEACAM5
|
[NCBI]
|
0.000210864
|
|
|
HBA2
|
[NCBI]
|
0.000204965
|
|
|
MTM1
|
[NCBI]
|
0.000204074
|
|
|
RCC1
|
[NCBI]
|
0.000204074
|
|
|
EGFR
|
[NCBI]
|
0.000203697
|
|
|
fabry disease
|
[NCBI]
|
0.000202997
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
0.00020244
|
|
|
CHM
|
[NCBI]
|
0.000200576
|
|
|
CFNS
|
[NCBI]
|
0.000197926
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
0.000193757
|
|
|
DYT1
|
[NCBI]
|
0.000193571
|
|
|
renal hamartomas, nephroblastomatosis, and fetal gigantism
|
[NCBI]
|
0.000189611
|
|
|
MCOPS1
|
[NCBI]
|
0.000189611
|
|
|
robinow syndrome, autosomal dominant
|
[NCBI]
|
0.000189611
|
|
|
CRH
|
[NCBI]
|
0.000189164
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
0.000186646
|
|
|
von willebrand disease, recessive form
|
[NCBI]
|
0.000186387
|
|
|
FSHMD1A
|
[NCBI]
|
0.000182913
|
|
|
BRCA1
|
[NCBI]
|
0.000181169
|
|
|
APL
|
[NCBI]
|
0.000172206
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000171086
|
|
|
ACHE
|
[NCBI]
|
0.000170879
|
|
|
IBD2
|
[NCBI]
|
0.000169716
|
|
|
LDLR
|
[NCBI]
|
0.000163212
|
|
|
ACADM
|
[NCBI]
|
0.00016293
|
|
|
PI
|
[NCBI]
|
0.000162824
|
|
|
cystinuria
|
[NCBI]
|
0.000162666
|
|
|
glycogen storage disease ii
|
[NCBI]
|
0.000161721
|
|
|
APOB
|
[NCBI]
|
0.000160886
|
|
|
PXE
|
[NCBI]
|
0.000160182
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
0.000155472
|
|
|
HPRT1
|
[NCBI]
|
0.000154659
|
|
|
stiff skin syndrome
|
[NCBI]
|
0.000152497
|
|
|
MPO
|
[NCBI]
|
0.000151618
|
|
|
phenylketonuria
|
[NCBI]
|
0.000148655
|
|
|
HGF
|
[NCBI]
|
0.000147043
|
|
|
FXTAS
|
[NCBI]
|
0.000146592
|
|
|
LPL
|
[NCBI]
|
0.000146058
|
|
|
pheochromocytoma
|
[NCBI]
|
0.000145765
|
|
|
LNS
|
[NCBI]
|
0.000144951
|
|
|
CCD
|
[NCBI]
|
0.000144782
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
0.000143064
|
|
|
AFP
|
[NCBI]
|
0.000142811
|
|
|
APOE
|
[NCBI]
|
0.000141139
|
|
|
weyers acrofacial dysostosis
|
[NCBI]
|
0.000140937
|
|
|
HBA1
|
[NCBI]
|
0.000137858
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
0.000137425
|
|
|
pygmy
|
[NCBI]
|
0.000137416
|
|
|
ACG1A
|
[NCBI]
|
0.000137416
|
|
|
OTSC1
|
[NCBI]
|
0.000137416
|
|
|
GTS
|
[NCBI]
|
0.000136476
|
|
|
galactokinase deficiency
|
[NCBI]
|
0.000136178
|
|
|
CJD
|
[NCBI]
|
0.00013214
|
|
|
CD
|
[NCBI]
|
0.00012992
|
|
|
CFTR
|
[NCBI]
|
0.000129676
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
0.00012899
|
|
|
HHC1
|
[NCBI]
|
0.00012899
|
|
|
PLP1
|
[NCBI]
|
0.000128082
|
|
|
F2
|
[NCBI]
|
0.000126806
|
|
|
MC4R
|
[NCBI]
|
0.000125727
|
|
|
short rib-polydactyly syndrome, type ii
|
[NCBI]
|
0.000124083
|
|
|
LRRK2
|
[NCBI]
|
0.000123642
|
|
|
GFAP
|
[NCBI]
|
0.000122923
|
|
|
HEXA
|
[NCBI]
|
0.000122563
|
|
|
HBG1
|
[NCBI]
|
0.000120633
|
|
|
factor vii deficiency
|
[NCBI]
|
0.000118925
|
|
|
SPD1
|
[NCBI]
|
0.000114776
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive
|
[NCBI]
|
0.000114776
|
|
|
PNDM
|
[NCBI]
|
0.000114776
|
|
|
fragile site 2q11
|
[NCBI]
|
0.00011388
|
|
|
ATM
|
[NCBI]
|
0.000113224
|
|
|
FEB1
|
[NCBI]
|
0.000112206
|
|
|
ST8
|
[NCBI]
|
0.000112206
|
|
|
esophageal cancer
|
[NCBI]
|
0.000108954
|
|
|
ND
|
[NCBI]
|
0.00010551
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
0.000105443
|
|
|
SANDO
|
[NCBI]
|
0.000104269
|
|
|
MYP2
|
[NCBI]
|
0.000101559
|
|
|
toenail dystrophy, isolated
|
[NCBI]
|
0.000100421
|
|
|
camptodactyly, tall stature, and hearing loss syndrome
|
[NCBI]
|
0.000100421
|
|
|
EVC
|
[NCBI]
|
0.000100211
|
|
|
TNFSF6
|
[NCBI]
|
0.000100204
|
|
|
ICP
|
[NCBI]
|
9.87049e-05
|
|
|
molybdenum cofactor deficiency
|
[NCBI]
|
9.87049e-05
|
|
|
FTD
|
[NCBI]
|
9.74161e-05
|
|
|
usher syndrome, type i
|
[NCBI]
|
9.68385e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
9.6482e-05
|
|
|
iron overload in africa
|
[NCBI]
|
9.61803e-05
|
|
|
SYNS1
|
[NCBI]
|
9.61803e-05
|
|
|
emanuel syndrome
|
[NCBI]
|
9.61803e-05
|
|
|
von willebrand disease
|
[NCBI]
|
9.60296e-05
|
|
|
CDSP
|
[NCBI]
|
9.49213e-05
|
|
|
NPC1
|
[NCBI]
|
9.43561e-05
|
|
|
GABEB
|
[NCBI]
|
9.41529e-05
|
|
|
EPO
|
[NCBI]
|
9.41394e-05
|
|
|
MBP
|
[NCBI]
|
9.20407e-05
|
|
|
AIC
|
[NCBI]
|
9.19671e-05
|
|
|
alopecia areata 1
|
[NCBI]
|
9.19671e-05
|
|
|
homocystinuria
|
[NCBI]
|
9.15218e-05
|
|
|
CASR
|
[NCBI]
|
9.02448e-05
|
|
|
CBAVD
|
[NCBI]
|
8.99196e-05
|
|
|
BCNS
|
[NCBI]
|
8.98154e-05
|
|
|
AVP
|
[NCBI]
|
8.9257e-05
|
|
|
NPPA
|
[NCBI]
|
8.92301e-05
|
|
|
trifunctional protein deficiency
|
[NCBI]
|
8.92161e-05
|
|
|
hematopoietic stem cell kinetics, control of
|
[NCBI]
|
8.92161e-05
|
|
|
APS1
|
[NCBI]
|
8.91899e-05
|
|
|
CHAT
|
[NCBI]
|
8.79995e-05
|
|
|
SLOS
|
[NCBI]
|
8.64572e-05
|
|
|
autonomic control, congenital failure of
|
[NCBI]
|
8.5968e-05
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
8.47969e-05
|
|
|
glutathione synthetase deficiency of erythrocytes, hemolytic anemia due to
|
[NCBI]
|
8.378e-05
|
|
|
cervical cancer
|
[NCBI]
|
8.378e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, infantile
|
[NCBI]
|
8.378e-05
|
|
|
IGAD1
|
[NCBI]
|
8.32888e-05
|
|
|
MRX1
|
[NCBI]
|
8.32888e-05
|
|
|
CCR5
|
[NCBI]
|
8.28424e-05
|
|
|
FA
|
[NCBI]
|
8.14606e-05
|
|
|
CAT
|
[NCBI]
|
8.08937e-05
|
|
|
PTS
|
[NCBI]
|
8.05793e-05
|
|
|
CGD
|
[NCBI]
|
7.94284e-05
|
|
|
ARSA
|
[NCBI]
|
7.90019e-05
|
|
|
deafness, conductive, with stapes fixation
|
[NCBI]
|
7.87912e-05
|
|
|
NF1
|
[NCBI]
|
7.87204e-05
|
|
|
giant platelet syndrome
|
[NCBI]
|
7.80519e-05
|
|
|
WRN
|
[NCBI]
|
7.7952e-05
|
|
|
HRPT2
|
[NCBI]
|
7.7705e-05
|
|
|
PMD
|
[NCBI]
|
7.7209e-05
|
|
|
sandhoff disease
|
[NCBI]
|
7.70208e-05
|
|
|
TTR
|
[NCBI]
|
7.58714e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
7.5429e-05
|
|
|
FIH
|
[NCBI]
|
7.46281e-05
|
|
|
hemophilia a
|
[NCBI]
|
7.44851e-05
|
|
|
alzheimer disease 2
|
[NCBI]
|
7.28522e-05
|
|
|
denys-drash syndrome
|
[NCBI]
|
7.28522e-05
|
|
|
TH
|
[NCBI]
|
7.26126e-05
|
|
|
fragile site 10q25
|
[NCBI]
|
7.25596e-05
|
|
|
porencephaly, familial
|
[NCBI]
|
7.25596e-05
|
|
|
glycogen storage disease v
|
[NCBI]
|
7.24281e-05
|
|
|
LAMB3
|
[NCBI]
|
7.12324e-05
|
|
|
TBG
|
[NCBI]
|
7.10233e-05
|
|
|
RET
|
[NCBI]
|
6.99935e-05
|
|
|
GIST
|
[NCBI]
|
6.96152e-05
|
|
|
temporal arteritis
|
[NCBI]
|
6.96043e-05
|
|
|
gaucher disease, type iii
|
[NCBI]
|
6.95055e-05
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
6.95055e-05
|
|
|
CPX
|
[NCBI]
|
6.95055e-05
|
|
|
EFNB1
|
[NCBI]
|
6.90152e-05
|
|
|
WS2E
|
[NCBI]
|
6.90102e-05
|
|
|
contiguous abcd1/dxs1375e deletion syndrome
|
[NCBI]
|
6.90102e-05
|
|
|
hyperhidrosis palmaris et plantaris
|
[NCBI]
|
6.90102e-05
|
|
|
HHF5
|
[NCBI]
|
6.90102e-05
|
|
|
skin fragility-woolly hair syndrome
|
[NCBI]
|
6.90102e-05
|
|
|
retinitis pigmentosa 37
|
[NCBI]
|
6.90102e-05
|
|
|
epilepsy, childhood absence, 3
|
[NCBI]
|
6.90102e-05
|
|
|
blood group--public systems
|
[NCBI]
|
6.90102e-05
|
|
|
phosphoserine aminotransferase deficiency
|
[NCBI]
|
6.90102e-05
|
|
|
epilepsy with grand mal seizures on awakening
|
[NCBI]
|
6.90102e-05
|
|
|
charcot-marie-tooth disease, dominant intermediate d
|
[NCBI]
|
6.90102e-05
|
|
|
carabelli anomaly of maxillary molar teeth
|
[NCBI]
|
6.90102e-05
|
|
|
fragile site 9q32
|
[NCBI]
|
6.90102e-05
|
|
|
acid phosphatase deficiency
|
[NCBI]
|
6.90102e-05
|
|
|
FSGS3
|
[NCBI]
|
6.90102e-05
|
|
|
SSS1
|
[NCBI]
|
6.90102e-05
|
|
|
cataract-ataxia-deafness-retardation syndrome
|
[NCBI]
|
6.90102e-05
|
|
|
nasal hyperpigmentation, familial transverse
|
[NCBI]
|
6.90102e-05
|
|
|
phosphatase, acid, of tissues
|
[NCBI]
|
6.90102e-05
|
|
|
hypertension, early-onset, autosomal dominant, with severe exacerbation in pregnancy
|
[NCBI]
|
6.90102e-05
|
|
|
CDG2B
|
[NCBI]
|
6.90102e-05
|
|
|
deafness, congenital, with inner ear agenesis, microtia, and microdontia
|
[NCBI]
|
6.90102e-05
|
|
|
hemopoietic proliferation
|
[NCBI]
|
6.90102e-05
|
|
|
sclerocornea, autosomal dominant
|
[NCBI]
|
6.90102e-05
|
|
|
thyroid hormone metabolism, abnormal
|
[NCBI]
|
6.90102e-05
|
|
|
blood group--en
|
[NCBI]
|
6.90102e-05
|
|
|
immunoglobulin d level in plasma, low
|
[NCBI]
|
6.90102e-05
|
|
|
POF2B
|
[NCBI]
|
6.90102e-05
|
|
|
erythrocytosis, familial, 2
|
[NCBI]
|
6.84635e-05
|
|
|
LGMD2I
|
[NCBI]
|
6.84635e-05
|
|
|
ATD1
|
[NCBI]
|
6.82362e-05
|
|
|
IGAN1
|
[NCBI]
|
6.82362e-05
|
|
|
SHFM3
|
[NCBI]
|
6.82362e-05
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
6.67357e-05
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
6.67357e-05
|
|
|
pta deficiency
|
[NCBI]
|
6.67066e-05
|
|
|
FMR1
|
[NCBI]
|
6.64898e-05
|
|
|
SDS
|
[NCBI]
|
6.53314e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1
|
[NCBI]
|
6.44664e-05
|
|
|
complement factor h deficiency
|
[NCBI]
|
6.44664e-05
|
|
|
RPGR
|
[NCBI]
|
6.43904e-05
|
|
|
FPLD3
|
[NCBI]
|
6.41129e-05
|
|
|
boomerang dysplasia
|
[NCBI]
|
6.41129e-05
|
|
|
choreoathetosis, hypothyroidism, and neonatal respiratory distress
|
[NCBI]
|
6.41129e-05
|
|
|
cherubism
|
[NCBI]
|
6.41129e-05
|
|
|
keratoderma, palmoplantar, with deafness
|
[NCBI]
|
6.41129e-05
|
|
|
thrombophilia
|
[NCBI]
|
6.41129e-05
|
|
|
apc gene
|
[NCBI]
|
6.3936e-05
|
|
|
pyruvate kinase deficiency of red cells
|
[NCBI]
|
6.3915e-05
|
|
|
COL17A1
|
[NCBI]
|
6.27521e-05
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
6.16892e-05
|
|
|
RB1
|
[NCBI]
|
6.09431e-05
|
|
|
FED
|
[NCBI]
|
6.08042e-05
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
6.0133e-05
|
|
|
SPP1
|
[NCBI]
|
6.01121e-05
|
|
|
SMAD4
|
[NCBI]
|
5.92466e-05
|
|
|
VHL
|
[NCBI]
|
5.91824e-05
|
|
|
C9
|
[NCBI]
|
5.77827e-05
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
5.74573e-05
|
|
|
HMS
|
[NCBI]
|
5.73736e-05
|
|
|
HHRH
|
[NCBI]
|
5.73736e-05
|
|
|
F3
|
[NCBI]
|
5.69605e-05
|
|
|
homocysteinemia
|
[NCBI]
|
5.69543e-05
|
|
|
RP3
|
[NCBI]
|
5.69543e-05
|
|
|
RP2
|
[NCBI]
|
5.672e-05
|
|
|
CLN3
|
[NCBI]
|
5.62975e-05
|
|
|
BLM
|
[NCBI]
|
5.62163e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
5.61036e-05
|
|
|
VUR1
|
[NCBI]
|
5.57031e-05
|
|
|
thrombocytopenia-absent radius syndrome
|
[NCBI]
|
5.57031e-05
|
|
|
HOXD13
|
[NCBI]
|
5.48919e-05
|
|
|
GNRH1
|
[NCBI]
|
5.48516e-05
|
|
|
BCPM
|
[NCBI]
|
5.47867e-05
|
|
|
FXN
|
[NCBI]
|
5.4486e-05
|
|
|
PD
|
[NCBI]
|
5.41355e-05
|
|
|
SLC4A1
|
[NCBI]
|
5.38504e-05
|
|
|
wilson disease
|
[NCBI]
|
5.38446e-05
|
|
|
OTC
|
[NCBI]
|
5.30766e-05
|
|
|
PTK2
|
[NCBI]
|
5.24957e-05
|
|
|
PGM1
|
[NCBI]
|
5.23941e-05
|
|
|
TPI1
|
[NCBI]
|
5.2369e-05
|
|
|
PMM2
|
[NCBI]
|
5.22899e-05
|
|
|
chondrodysplasia, grebe type
|
[NCBI]
|
5.17965e-05
|
|
|
EPD
|
[NCBI]
|
5.17965e-05
|
|
|
EVR2
|
[NCBI]
|
5.17965e-05
|
|
|
myopathy, myosin storage
|
[NCBI]
|
5.17965e-05
|
|
|
mal de meleda
|
[NCBI]
|
5.17965e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 3
|
[NCBI]
|
5.17965e-05
|
|
|
creatine deficiency syndrome, x-linked
|
[NCBI]
|
5.17965e-05
|
|
|
LADD
|
[NCBI]
|
5.17965e-05
|
|
|
galactosemia
|
[NCBI]
|
5.17038e-05
|
|
|
KAL2
|
[NCBI]
|
5.14158e-05
|
|
|
GEFS+
|
[NCBI]
|
5.14158e-05
|
|
|
TRAPPC2
|
[NCBI]
|
5.10006e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
5.07839e-05
|
|
|
MOCS1
|
[NCBI]
|
5.04738e-05
|
|
|
HBD
|
[NCBI]
|
5.04292e-05
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
5.02216e-05
|
|
|
breast cancer-related regulator of tp53
|
[NCBI]
|
4.9963e-05
|
|
|
GNAS
|
[NCBI]
|
4.99027e-05
|
|
|
PARK8
|
[NCBI]
|
4.87175e-05
|
|
|
maple syrup urine disease
|
[NCBI]
|
4.86886e-05
|
|
|
CCM
|
[NCBI]
|
4.86886e-05
|
|
|
HHF2
|
[NCBI]
|
4.86886e-05
|
|
|
AN2
|
[NCBI]
|
4.86886e-05
|
|
|
SHBG
|
[NCBI]
|
4.84035e-05
|
|
|
HEXB
|
[NCBI]
|
4.8285e-05
|
|
|
POLG
|
[NCBI]
|
4.75335e-05
|
|
|
BMPR2
|
[NCBI]
|
4.74824e-05
|
|
|
osteogenic sarcoma
|
[NCBI]
|
4.70633e-05
|
|
|
CMH4
|
[NCBI]
|
4.70633e-05
|
|
|
CLPED1
|
[NCBI]
|
4.70633e-05
|
|
|
hexokinase deficiency hemolytic anemia
|
[NCBI]
|
4.70633e-05
|
|
|
SYM1
|
[NCBI]
|
4.70633e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, lethal neonatal
|
[NCBI]
|
4.70633e-05
|
|
|
dyskeratosis congenita, autosomal dominant
|
[NCBI]
|
4.70633e-05
|
|
|
CADASIL
|
[NCBI]
|
4.70142e-05
|
|
|
FGFR3
|
[NCBI]
|
4.64082e-05
|
|
|
osteogenesis imperfecta, type iii
|
[NCBI]
|
4.61962e-05
|
|
|
ATRX
|
[NCBI]
|
4.60879e-05
|
|
|
ARPKD
|
[NCBI]
|
4.58517e-05
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
4.58517e-05
|
|
|
PROS1
|
[NCBI]
|
4.57741e-05
|
|
|
CREBBP
|
[NCBI]
|
4.5392e-05
|
|
|
COL1A2
|
[NCBI]
|
4.52804e-05
|
|
|
malaria, susceptibility to
|
[NCBI]
|
4.52682e-05
|
|
|
CMTX1
|
[NCBI]
|
4.52682e-05
|
|
|
vitamin d-dependent rickets, type ii
|
[NCBI]
|
4.52682e-05
|
|
|
kartagener syndrome
|
[NCBI]
|
4.52682e-05
|
|
|
HSCR1
|
[NCBI]
|
4.52021e-05
|
|
|
MSH6
|
[NCBI]
|
4.48356e-05
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
4.39316e-05
|
|
|
MEFV
|
[NCBI]
|
4.39316e-05
|
|
|
GHR
|
[NCBI]
|
4.39171e-05
|
|
|
PPH1
|
[NCBI]
|
4.38341e-05
|
|
|
LFS1
|
[NCBI]
|
4.35918e-05
|
|
|
sialuria
|
[NCBI]
|
4.29713e-05
|
|
|
aspermiogenesis factor
|
[NCBI]
|
4.29713e-05
|
|
|
spondyloepimetaphyseal dysplasia, strudwick type
|
[NCBI]
|
4.29713e-05
|
|
|
SXI1
|
[NCBI]
|
4.29713e-05
|
|
|
hepatitis b virus, susceptibility to
|
[NCBI]
|
4.29713e-05
|
|
|
keratitis-ichthyosis-deafness syndrome, autosomal dominant
|
[NCBI]
|
4.29713e-05
|
|
|
POU1F1
|
[NCBI]
|
4.2218e-05
|
|
|
F13A1
|
[NCBI]
|
4.21534e-05
|
|
|
cholesteryl ester transfer protein deficiency
|
[NCBI]
|
4.1886e-05
|
|
|
filaminopathy, autosomal dominant
|
[NCBI]
|
4.1886e-05
|
|
|
fibromuscular dysplasia of arteries
|
[NCBI]
|
4.1886e-05
|
|
|
diabetes mellitus, transient neonatal, 2
|
[NCBI]
|
4.1886e-05
|
|
|
schizencephaly
|
[NCBI]
|
4.1886e-05
|
|
|
orotic aciduria ii
|
[NCBI]
|
4.1886e-05
|
|
|
aarskog syndrome
|
[NCBI]
|
4.1886e-05
|
|
|
deafness, congenital, with total albinism
|
[NCBI]
|
4.1886e-05
|
|
|
dermal ridges, nelson syndrome
|
[NCBI]
|
4.1886e-05
|
|
|
glycogen storage disease of heart, lethal congenital
|
[NCBI]
|
4.1886e-05
|
|
|
corpus callosum, agenesis of, with abnormal genitalia
|
[NCBI]
|
4.1886e-05
|
|
|
mcdonough syndrome
|
[NCBI]
|
4.1886e-05
|
|
|
SHEP4
|
[NCBI]
|
4.1886e-05
|
|
|
hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration
|
[NCBI]
|
4.1886e-05
|
|
|
AOIII
|
[NCBI]
|
4.1886e-05
|
|
|
pseudopapilledema, ocular hypotelorism, blepharophimosis, and hand anomalies
|
[NCBI]
|
4.1886e-05
|
|
|
anal sphincter myopathy, internal
|
[NCBI]
|
4.1886e-05
|
|
|
HMPS2
|
[NCBI]
|
4.1886e-05
|
|
|
bronchiectasis
|
[NCBI]
|
4.1886e-05
|
|
|
3-@hydroxyacyl-coa dehydrogenase deficiency
|
[NCBI]
|
4.1886e-05
|
|
|
ehlers-danlos syndrome, autosomal recessive, cardiac valvular form
|
[NCBI]
|
4.1886e-05
|
|
|
chromosome 18 pericentric inversion
|
[NCBI]
|
4.1886e-05
|
|
|
SCA16
|
[NCBI]
|
4.1886e-05
|
|
|
glycinuria with or without oxalate urolithiasis
|
[NCBI]
|
4.1886e-05
|
|
|
uric acid nephrolithiasis, susceptibility to
|
[NCBI]
|
4.1886e-05
|
|
|
MCOPS5
|
[NCBI]
|
4.1886e-05
|
|
|
sjogren-larsson-like ichthyosis without cns or eye involvement
|
[NCBI]
|
4.1886e-05
|
|
|
deafness, autosomal recessive
|
[NCBI]
|
4.1886e-05
|
|
|
LFS2
|
[NCBI]
|
4.1886e-05
|
|
|
chands
|
[NCBI]
|
4.1886e-05
|
|
|
mental retardation, x-linked, with brachydactyly and macroglossia
|
[NCBI]
|
4.1886e-05
|
|
|
MODY6
|
[NCBI]
|
4.1886e-05
|
|
|
CC
|
[NCBI]
|
4.1886e-05
|
|
|
muscular dystrophy, scapulohumeral
|
[NCBI]
|
4.1886e-05
|
|
|
charcot-marie-tooth disease, dominant intermediate c
|
[NCBI]
|
4.1886e-05
|
|
|
epidermolysis bullosa simplex with migratory circinate erythema
|
[NCBI]
|
4.1886e-05
|
|
|
AME2
|
[NCBI]
|
4.1886e-05
|
|
|
ADRB3
|
[NCBI]
|
4.1829e-05
|
|
|
FGA
|
[NCBI]
|
4.16329e-05
|
|
|
glycogen storage disease iii
|
[NCBI]
|
4.1616e-05
|
|
|
DRD
|
[NCBI]
|
4.1616e-05
|
|
|
TGD
|
[NCBI]
|
4.1616e-05
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
4.1616e-05
|
|
|
AIRE
|
[NCBI]
|
4.15013e-05
|
|
|
HD
|
[NCBI]
|
4.08872e-05
|
|
|
GALK1
|
[NCBI]
|
4.06272e-05
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
4.05868e-05
|
|
|
ADCYAP1
|
[NCBI]
|
4.03591e-05
|
|
|
MAFD6
|
[NCBI]
|
4.01871e-05
|
|
|
AHO
|
[NCBI]
|
4.00701e-05
|
|
|
NDP
|
[NCBI]
|
3.98565e-05
|
|
|
HR
|
[NCBI]
|
3.94922e-05
|
|
|
CPT2
|
[NCBI]
|
3.94922e-05
|
|
|
LQT1
|
[NCBI]
|
3.94504e-05
|
|
|
MCOPS3
|
[NCBI]
|
3.93833e-05
|
|
|
SLSN1
|
[NCBI]
|
3.93833e-05
|
|
|
BDC
|
[NCBI]
|
3.93833e-05
|
|
|
feingold syndrome
|
[NCBI]
|
3.93833e-05
|
|
|
IDUA
|
[NCBI]
|
3.93394e-05
|
|
|
GNRHR
|
[NCBI]
|
3.92607e-05
|
|
|
ATP8B1
|
[NCBI]
|
3.92336e-05
|
|
|
ornithine aminotransferase deficiency
|
[NCBI]
|
3.91187e-05
|
|
|
lymphocyte cytosol polypeptide, 20-kd
|
[NCBI]
|
3.86923e-05
|
|
|
actin-binding protein, 34-kd
|
[NCBI]
|
3.86923e-05
|
|
|
INSR
|
[NCBI]
|
3.85318e-05
|
|
|
LCAT
|
[NCBI]
|
3.84558e-05
|
|
|
ATP2A2
|
[NCBI]
|
3.84173e-05
|
|
|
PLOD1
|
[NCBI]
|
3.84173e-05
|
|
|
CHEK2
|
[NCBI]
|
3.84033e-05
|
|
|
wolman disease
|
[NCBI]
|
3.84033e-05
|
|
|
TS
|
[NCBI]
|
3.81196e-05
|
|
|
APC
|
[NCBI]
|
3.80072e-05
|
|
|
SEDC
|
[NCBI]
|
3.75607e-05
|
|
|
OCRL
|
[NCBI]
|
3.75607e-05
|
|
|
hyperekplexia, hereditary
|
[NCBI]
|
3.75607e-05
|
|
|
DLD
|
[NCBI]
|
3.73969e-05
|
|
|
NR3C2
|
[NCBI]
|
3.73969e-05
|
|
|
NODAL
|
[NCBI]
|
3.73196e-05
|
|
|
PKD2
|
[NCBI]
|
3.71552e-05
|
|
|
STK11
|
[NCBI]
|
3.70353e-05
|
|
|
MAFD1
|
[NCBI]
|
3.65797e-05
|
|
|
CDH23
|
[NCBI]
|
3.64262e-05
|
|
|
PINK1
|
[NCBI]
|
3.64262e-05
|
|
|
ALPS
|
[NCBI]
|
3.62186e-05
|
|
|
CYLD
|
[NCBI]
|
3.62023e-05
|
|
|
HPE2
|
[NCBI]
|
3.62023e-05
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
3.62023e-05
|
|
|
glutathione synthetase deficiency
|
[NCBI]
|
3.62023e-05
|
|
|
SMDP1
|
[NCBI]
|
3.62023e-05
|
|
|
SEDT
|
[NCBI]
|
3.62023e-05
|
|
|
acheiropody
|
[NCBI]
|
3.62023e-05
|
|
|
SPTA1
|
[NCBI]
|
3.61636e-05
|
|
|
LS
|
[NCBI]
|
3.61634e-05
|
|
|
LCA1
|
[NCBI]
|
3.57022e-05
|
|
|
UGT1A1
|
[NCBI]
|
3.56819e-05
|
|
|
SLC7A9
|
[NCBI]
|
3.56096e-05
|
|
|
SRD5A2
|
[NCBI]
|
3.55008e-05
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
3.48633e-05
|
|
|
PAX2
|
[NCBI]
|
3.46171e-05
|
|
|
CYP17A1
|
[NCBI]
|
3.4522e-05
|
|
|
SMN1
|
[NCBI]
|
3.44902e-05
|
|
|
GCCR
|
[NCBI]
|
3.42897e-05
|
|
|
MEG3
|
[NCBI]
|
3.40656e-05
|
|
|
tyrosinemia, type i
|
[NCBI]
|
3.39351e-05
|
|
|
HEMB
|
[NCBI]
|
3.39071e-05
|
|
|
PKD1
|
[NCBI]
|
3.38343e-05
|
|
|
GCK
|
[NCBI]
|
3.37592e-05
|
|
|
MPZ
|
[NCBI]
|
3.37592e-05
|
|
|
MEN1
|
[NCBI]
|
3.37592e-05
|
|
|
adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency
|
[NCBI]
|
3.33565e-05
|
|
|
thiopurine s-methyltransferase deficiency
|
[NCBI]
|
3.33565e-05
|
|
|
monilethrix
|
[NCBI]
|
3.33565e-05
|
|
|
ED2
|
[NCBI]
|
3.33565e-05
|
|
|
NM
|
[NCBI]
|
3.33565e-05
|
|
|
OPD1
|
[NCBI]
|
3.33565e-05
|
|
|
papillorenal syndrome
|
[NCBI]
|
3.33565e-05
|
|
|
septooptic dysplasia
|
[NCBI]
|
3.33565e-05
|
|
|
DYT1
|
[NCBI]
|
3.29618e-05
|
|
|
MEN2A
|
[NCBI]
|
3.28764e-05
|
|
|
factor x deficiency
|
[NCBI]
|
3.28058e-05
|
|
|
TSC1
|
[NCBI]
|
3.28058e-05
|
|
|
MCOLN1
|
[NCBI]
|
3.26595e-05
|
|
|
MUC1
|
[NCBI]
|
3.25441e-05
|
|
|
AOS
|
[NCBI]
|
3.24727e-05
|
|
|
PPSH
|
[NCBI]
|
3.22792e-05
|
|
|
SCIDX1
|
[NCBI]
|
3.22747e-05
|
|
|
HBG2
|
[NCBI]
|
3.22622e-05
|
|
|
COL7A1
|
[NCBI]
|
3.22622e-05
|
|
|
NOG
|
[NCBI]
|
3.21848e-05
|
|
|
IGF2R
|
[NCBI]
|
3.21848e-05
|
|
|
TSC2
|
[NCBI]
|
3.21307e-05
|
|
|
CIDX
|
[NCBI]
|
3.20527e-05
|
|
|
DFNB21
|
[NCBI]
|
3.20527e-05
|
|
|
PFIC3
|
[NCBI]
|
3.20527e-05
|
|
|
CSNBAD2
|
[NCBI]
|
3.20527e-05
|
|
|
insulin-like growth factor i, resistance to
|
[NCBI]
|
3.20527e-05
|
|
|
phosphoglycerate dehydrogenase deficiency
|
[NCBI]
|
3.20527e-05
|
|
|
MRX63
|
[NCBI]
|
3.20527e-05
|
|
|
CLN10
|
[NCBI]
|
3.20527e-05
|
|
|
PEOA4
|
[NCBI]
|
3.20527e-05
|
|
|
MADB
|
[NCBI]
|
3.20527e-05
|
|
|
ehlers-danlos-like syndrome due to tenascin-x deficiency
|
[NCBI]
|
3.20527e-05
|
|
|
CMD1P
|
[NCBI]
|
3.20527e-05
|
|
|
stapes ankylosis with broad thumb and toes
|
[NCBI]
|
3.20527e-05
|
|
|
polydactyly
|
[NCBI]
|
3.20527e-05
|
|
|
arcus corneae
|
[NCBI]
|
3.20527e-05
|
|
|
moved to 310600
|
[NCBI]
|
3.20527e-05
|
|
|
FEB8
|
[NCBI]
|
3.20527e-05
|
|
|
spherocytosis, autosomal recessive
|
[NCBI]
|
3.20527e-05
|
|
|
MRX46
|
[NCBI]
|
3.20527e-05
|
|
|
egasyn
|
[NCBI]
|
3.20527e-05
|
|
|
ovarian hyperstimulation syndrome
|
[NCBI]
|
3.20527e-05
|
|
|
ARTS
|
[NCBI]
|
3.20527e-05
|
|
|
abdominal body fat distribution
|
[NCBI]
|
3.20527e-05
|
|
|
chondrosarcoma
|
[NCBI]
|
3.20527e-05
|
|
|
ACFD
|
[NCBI]
|
3.20527e-05
|
|
|
SPS
|
[NCBI]
|
3.20527e-05
|
|
|
bernard-soulier syndrome, benign autosomal dominant
|
[NCBI]
|
3.20527e-05
|
|
|
EDMD3
|
[NCBI]
|
3.20527e-05
|
|
|
preaxial deficiency, postaxial polydactyly, and hypospadias
|
[NCBI]
|
3.20527e-05
|
|
|
ovarian teratoma
|
[NCBI]
|
3.20527e-05
|
|
|
CVT
|
[NCBI]
|
3.20527e-05
|
|
|
HANAC
|
[NCBI]
|
3.20527e-05
|
|
|
thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis
|
[NCBI]
|
3.20527e-05
|
|
|
hepatitis b vaccine, response to
|
[NCBI]
|
3.20527e-05
|
|
|
parotid proline-rich salivary protein pc
|
[NCBI]
|
3.20527e-05
|
|
|
NS4
|
[NCBI]
|
3.20527e-05
|
|
|
LAM
|
[NCBI]
|
3.1502e-05
|
|
|
LMNA
|
[NCBI]
|
3.10221e-05
|
|
|
IL2
|
[NCBI]
|
3.0953e-05
|
|
|
CORDX1
|
[NCBI]
|
3.0792e-05
|
|
|
JME
|
[NCBI]
|
3.0792e-05
|
|
|
BHD
|
[NCBI]
|
3.0792e-05
|
|
|
diabetes insipidus, nephrogenic, autosomal
|
[NCBI]
|
3.0792e-05
|
|
|
tetralogy of fallot
|
[NCBI]
|
3.0792e-05
|
|
|
OPD2
|
[NCBI]
|
3.0792e-05
|
|
|
asplenia with cardiovascular anomalies
|
[NCBI]
|
3.0792e-05
|
|
|
NPC1
|
[NCBI]
|
3.07201e-05
|
|
|
COL4A5
|
[NCBI]
|
3.07201e-05
|
|
|
KCNJ11
|
[NCBI]
|
3.07201e-05
|
|
|
HS
|
[NCBI]
|
3.07085e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
3.07e-05
|
|
|
MLH1
|
[NCBI]
|
3.05327e-05
|
|
|
EVC
|
[NCBI]
|
3.02128e-05
|
|
|
MYBPC3
|
[NCBI]
|
3.01792e-05
|
|
|
APOA1
|
[NCBI]
|
3.01495e-05
|
|
|
IP
|
[NCBI]
|
3.01241e-05
|
|
|
SLC40A1
|
[NCBI]
|
3.00286e-05
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
3.00286e-05
|
|
|
NPS
|
[NCBI]
|
2.99275e-05
|
|
|
MC1R
|
[NCBI]
|
2.94486e-05
|
|
|
TSHR
|
[NCBI]
|
2.94016e-05
|
|
|
LHCGR
|
[NCBI]
|
2.92602e-05
|
|
|
KSS
|
[NCBI]
|
2.90896e-05
|
|
|
ATP1A2
|
[NCBI]
|
2.90749e-05
|
|
|
menkes disease
|
[NCBI]
|
2.90566e-05
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
2.8909e-05
|
|
|
myeloproliferative syndrome, transient
|
[NCBI]
|
2.8909e-05
|
|
|
MSH2
|
[NCBI]
|
2.87988e-05
|
|
|
CYP1A1
|
[NCBI]
|
2.8739e-05
|
|
|
SOX10
|
[NCBI]
|
2.87186e-05
|
|
|
propionic acidemia
|
[NCBI]
|
2.84667e-05
|
|
|
HPE3
|
[NCBI]
|
2.84667e-05
|
|
|
danon disease
|
[NCBI]
|
2.84667e-05
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
2.80973e-05
|
|
|
orotic aciduria i
|
[NCBI]
|
2.80456e-05
|
|
|
RNASEL
|
[NCBI]
|
2.80456e-05
|
|
|
RAD51
|
[NCBI]
|
2.80456e-05
|
|
|
PRNP
|
[NCBI]
|
2.76688e-05
|
|
|
ALG6
|
[NCBI]
|
2.76015e-05
|
|
|
CSHL1
|
[NCBI]
|
2.76015e-05
|
|
|
HK3
|
[NCBI]
|
2.76015e-05
|
|
|
ACH
|
[NCBI]
|
2.74004e-05
|
|
|
leber optic atrophy
|
[NCBI]
|
2.74002e-05
|
|
|
SURF1
|
[NCBI]
|
2.70826e-05
|
|
|
MYO7A
|
[NCBI]
|
2.69154e-05
|
|
|
MBL2
|
[NCBI]
|
2.66525e-05
|
|
|
CVID
|
[NCBI]
|
2.64527e-05
|
|
|
PSACH
|
[NCBI]
|
2.64481e-05
|
|
|
SGBS1
|
[NCBI]
|
2.64197e-05
|
|
|
DJS
|
[NCBI]
|
2.64197e-05
|
|
|
PARK6
|
[NCBI]
|
2.63474e-05
|
|
|
SLC6A8
|
[NCBI]
|
2.61784e-05
|
|
|
MUTYH
|
[NCBI]
|
2.61784e-05
|
|
|
HADHA
|
[NCBI]
|
2.61784e-05
|
|
|
PCCB
|
[NCBI]
|
2.61784e-05
|
|
|
HAE III
|
[NCBI]
|
2.58948e-05
|
|
|
CAMT
|
[NCBI]
|
2.58948e-05
|
|
|
ARMD2
|
[NCBI]
|
2.58948e-05
|
|
|
HHF4
|
[NCBI]
|
2.58948e-05
|
|
|
TBDN
|
[NCBI]
|
2.58948e-05
|
|
|
epidermolysis bullosa simplex, ogna type
|
[NCBI]
|
2.58948e-05
|
|
|
RP18
|
[NCBI]
|
2.58948e-05
|
|
|
immunodeficiency with hyper-igm, type 2
|
[NCBI]
|
2.58948e-05
|
|
|
cryohydrocytosis, stomatin-deficient, with mental retardation, seizures, cataracts, and massive hepatosplenomegaly
|
[NCBI]
|
2.58948e-05
|
|
|
heterotaxy, visceral, 2, autosomal
|
[NCBI]
|
2.58948e-05
|
|
|
bleeding disorder due to p2ry12 defect
|
[NCBI]
|
2.58948e-05
|
|
|
CORDX3
|
[NCBI]
|
2.58948e-05
|
|
|
2-@methylbutyryl-coa dehydrogenase deficiency
|
[NCBI]
|
2.58948e-05
|
|
|
RP19
|
[NCBI]
|
2.58948e-05
|
|
|
hydroxyprolinemia
|
[NCBI]
|
2.58948e-05
|
|
|
fecundity gene, booroola, of sheep, homolog of
|
[NCBI]
|
2.58948e-05
|
|
|
platelet disorder, familial, with associated myeloid malignancy
|
[NCBI]
|
2.58948e-05
|
|
|
ACG1B
|
[NCBI]
|
2.58948e-05
|
|
|
CSNBAD1
|
[NCBI]
|
2.58948e-05
|
|
|
cardiac arrhythmia, ankyrin-b-related
|
[NCBI]
|
2.58948e-05
|
|
|
syndactyly, type iii
|
[NCBI]
|
2.58948e-05
|
|
|
PRD
|
[NCBI]
|
2.58948e-05
|
|
|
complement component 4, partial deficiency of
|
[NCBI]
|
2.58948e-05
|
|
|
oncocytoma
|
[NCBI]
|
2.58948e-05
|
|
|
dyserythropoietic anemia with thrombocytopenia
|
[NCBI]
|
2.58948e-05
|
|
|
simpson-golabi-behmel syndrome, type 2
|
[NCBI]
|
2.58948e-05
|
|
|
acyl-coa dehydrogenase, long-chain, deficiency of
|
[NCBI]
|
2.58948e-05
|
|
|
CSB
|
[NCBI]
|
2.58948e-05
|
|
|
mevalonic aciduria
|
[NCBI]
|
2.58948e-05
|
|
|
proprotein convertase 1 deficiency
|
[NCBI]
|
2.58948e-05
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
2.58314e-05
|
|
|
ADRB2
|
[NCBI]
|
2.58073e-05
|
|
|
GBA
|
[NCBI]
|
2.5679e-05
|
|
|
HLA-A
|
[NCBI]
|
2.5679e-05
|
|
|
WT1
|
[NCBI]
|
2.56123e-05
|
|
|
ADD2
|
[NCBI]
|
2.54973e-05
|
|
|
HRPT2
|
[NCBI]
|
2.54973e-05
|
|
|
P2RY12
|
[NCBI]
|
2.54973e-05
|
|
|
chromosome 17q21.31 microdeletion syndrome
|
[NCBI]
|
2.54973e-05
|
|
|
NDUFS8
|
[NCBI]
|
2.54973e-05
|
|
|
CA2
|
[NCBI]
|
2.53268e-05
|
|
|
PHOX2B
|
[NCBI]
|
2.53268e-05
|
|
|
RHCE
|
[NCBI]
|
2.52785e-05
|
|
|
TPMT
|
[NCBI]
|
2.52587e-05
|
|
|
LGMD2A
|
[NCBI]
|
2.51286e-05
|
|
|
glycogen storage disease vii
|
[NCBI]
|
2.51286e-05
|
|
|
PGL1
|
[NCBI]
|
2.51286e-05
|
|
|
PARK2
|
[NCBI]
|
2.51286e-05
|
|
|
P2RY8
|
[NCBI]
|
2.49807e-05
|
|
|
IZUMO1
|
[NCBI]
|
2.49807e-05
|
|
|
kiaa2022
|
[NCBI]
|
2.49807e-05
|
|
|
complement component c1q, fibroblast type
|
[NCBI]
|
2.49807e-05
|
|
|
ras-related on chromosome 22
|
[NCBI]
|
2.49807e-05
|
|
|
mental retardation, x-linked, south african type
|
[NCBI]
|
2.49807e-05
|
|
|
OR1F1
|
[NCBI]
|
2.49807e-05
|
|
|
MOSPD3
|
[NCBI]
|
2.49807e-05
|
|
|
SOHLH1
|
[NCBI]
|
2.49807e-05
|
|
|
MOSPD1
|
[NCBI]
|
2.49807e-05
|
|
|
FFI
|
[NCBI]
|
2.49179e-05
|
|
|
lynch syndrome i
|
[NCBI]
|
2.48203e-05
|
|
|
FY
|
[NCBI]
|
2.47654e-05
|
|
|
PPARA
|
[NCBI]
|
2.46878e-05
|
|
|
PYGM
|
[NCBI]
|
2.45225e-05
|
|
|
acromegaly
|
[NCBI]
|
2.44075e-05
|
|
|
PHA
|
[NCBI]
|
2.44075e-05
|
|
|
OPTB3
|
[NCBI]
|
2.44075e-05
|
|
|
HPC1
|
[NCBI]
|
2.44075e-05
|
|
|
SPG2
|
[NCBI]
|
2.44075e-05
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
2.42673e-05
|
|
|
breast cancer
|
[NCBI]
|
2.40379e-05
|
|
|
HCH
|
[NCBI]
|
2.38984e-05
|
|
|
ED1
|
[NCBI]
|
2.37875e-05
|
|
|
ABCA4
|
[NCBI]
|
2.37833e-05
|
|
|
SLC5A5
|
[NCBI]
|
2.37609e-05
|
|
|
ATOH1
|
[NCBI]
|
2.37383e-05
|
|
|
NR5A1
|
[NCBI]
|
2.36003e-05
|
|
|
XDH
|
[NCBI]
|
2.34378e-05
|
|
|
PMP22
|
[NCBI]
|
2.33063e-05
|
|
|
SDHD
|
[NCBI]
|
2.30382e-05
|
|
|
PAX3
|
[NCBI]
|
2.29111e-05
|
|
|
VWS
|
[NCBI]
|
2.288e-05
|
|
|
HIGM1
|
[NCBI]
|
2.27252e-05
|
|
|
OCA2
|
[NCBI]
|
2.27252e-05
|
|
|
meningioma, familial
|
[NCBI]
|
2.27252e-05
|
|
|
PTHLH
|
[NCBI]
|
2.27237e-05
|
|
|
glycogen storage disease iv
|
[NCBI]
|
2.26249e-05
|
|
|
FBS
|
[NCBI]
|
2.26249e-05
|
|
|
glucose transport defect, blood-brain barrier
|
[NCBI]
|
2.26249e-05
|
|
|
EAOH
|
[NCBI]
|
2.26249e-05
|
|
|
MSX1
|
[NCBI]
|
2.23509e-05
|
|
|
LHB
|
[NCBI]
|
2.23509e-05
|
|
|
PEPB
|
[NCBI]
|
2.22298e-05
|
|
|
DYNC1H1
|
[NCBI]
|
2.22298e-05
|
|
|
PRH2
|
[NCBI]
|
2.22298e-05
|
|
|
MAF
|
[NCBI]
|
2.22298e-05
|
|
|
hemojuvelin
|
[NCBI]
|
2.22298e-05
|
|
|
SLC34A1
|
[NCBI]
|
2.22298e-05
|
|
|
SLC3A1
|
[NCBI]
|
2.1696e-05
|
|
|
AS
|
[NCBI]
|
2.16941e-05
|
|
|
SMA3
|
[NCBI]
|
2.16056e-05
|
|
|
GCPS
|
[NCBI]
|
2.16056e-05
|
|
|
CLN3
|
[NCBI]
|
2.16056e-05
|
|
|
TNFRSF6
|
[NCBI]
|
2.15544e-05
|
|
|
hyperprolinemia, type ii
|
[NCBI]
|
2.14824e-05
|
|
|
PCWH
|
[NCBI]
|
2.14824e-05
|
|
|
ALSG
|
[NCBI]
|
2.14824e-05
|
|
|
MRX21
|
[NCBI]
|
2.14824e-05
|
|
|
anderson disease
|
[NCBI]
|
2.14824e-05
|
|
|
glycogen storage disease 0, muscle
|
[NCBI]
|
2.14824e-05
|
|
|
RP7
|
[NCBI]
|
2.14824e-05
|
|
|
thrombophilia due to deficiency of activated protein c cofactor
|
[NCBI]
|
2.14824e-05
|
|
|
PFM2
|
[NCBI]
|
2.14824e-05
|
|
|
OUBR
|
[NCBI]
|
2.14824e-05
|
|
|
witkop syndrome
|
[NCBI]
|
2.14824e-05
|
|
|
epidermolysis bullosa of hands and feet
|
[NCBI]
|
2.14824e-05
|
|
|
young syndrome
|
[NCBI]
|
2.14824e-05
|
|
|
DFNB2
|
[NCBI]
|
2.14824e-05
|
|
|
cystinosis, adult nonnephropathic
|
[NCBI]
|
2.14824e-05
|
|
|
recombinant chromosome 8 syndrome
|
[NCBI]
|
2.14824e-05
|
|
|
beta thalassemia, dominant inclusion body type
|
[NCBI]
|
2.14824e-05
|
|
|
enterokinase deficiency
|
[NCBI]
|
2.14824e-05
|
|
|
AH
|
[NCBI]
|
2.14824e-05
|
|
|
dentinogenesis imperfecta, shields type iii
|
[NCBI]
|
2.14824e-05
|
|
|
JAE
|
[NCBI]
|
2.14824e-05
|
|
|
mental retardation, x-linked, with cerebellar hypoplasia and distinctive facial appearance
|
[NCBI]
|
2.14824e-05
|
|
|
anemia, hypochromic microcytic
|
[NCBI]
|
2.14824e-05
|
|
|
retinitis pigmentosa, x-linked, with recurrent respiratory infections
|
[NCBI]
|
2.14824e-05
|
|
|
keratosis palmoplantaris striata i
|
[NCBI]
|
2.14824e-05
|
|
|
white sponge nevus of cannon
|
[NCBI]
|
2.14824e-05
|
|
|
spondylocarpotarsal synostosis syndrome
|
[NCBI]
|
2.14824e-05
|
|
|
cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency
|
[NCBI]
|
2.14824e-05
|
|
|
ovarian cancer, epithelial
|
[NCBI]
|
2.14824e-05
|
|
|
PC2
|
[NCBI]
|
2.14824e-05
|
|
|
AVSD2
|
[NCBI]
|
2.14824e-05
|
|
|
melorheostosis
|
[NCBI]
|
2.14824e-05
|
|
|
melanoma-pancreatic cancer syndrome
|
[NCBI]
|
2.14824e-05
|
|
|
hawkinsinuria
|
[NCBI]
|
2.14824e-05
|
|
|
PDB1
|
[NCBI]
|
2.14824e-05
|
|
|
renal tubular acidosis, distal, with hemolytic anemia
|
[NCBI]
|
2.14824e-05
|
|
|
NS1
|
[NCBI]
|
2.11048e-05
|
|
|
EXT1
|
[NCBI]
|
2.10711e-05
|
|
|
IL2RG
|
[NCBI]
|
2.10711e-05
|
|
|
NRAS
|
[NCBI]
|
2.10711e-05
|
|
|
GALC
|
[NCBI]
|
2.10711e-05
|
|
|
XIST
|
[NCBI]
|
2.09864e-05
|
|
|
PARK2
|
[NCBI]
|
2.09864e-05
|
|
|
IBM2
|
[NCBI]
|
2.09818e-05
|
|
|
AIED
|
[NCBI]
|
2.09818e-05
|
|
|
ESCS
|
[NCBI]
|
2.09818e-05
|
|
|
KRTHB6
|
[NCBI]
|
2.09117e-05
|
|
|
LMBR1
|
[NCBI]
|
2.09117e-05
|
|
|
SFN
|
[NCBI]
|
2.09117e-05
|
|
|
WAS
|
[NCBI]
|
2.07419e-05
|
|
|
ADHD
|
[NCBI]
|
2.07383e-05
|
|
|
OCA1A
|
[NCBI]
|
2.05367e-05
|
|
|
CDG1A
|
[NCBI]
|
2.05367e-05
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
2.0418e-05
|
|
|
PTCH1
|
[NCBI]
|
1.99019e-05
|
|
|
ITGA2B
|
[NCBI]
|
1.99019e-05
|
|
|
IFNGR1
|
[NCBI]
|
1.99019e-05
|
|
|
DBA
|
[NCBI]
|
1.98479e-05
|
|
|
FOXF1
|
[NCBI]
|
1.97433e-05
|
|
|
ZMPSTE24
|
[NCBI]
|
1.97433e-05
|
|
|
SLC17A5
|
[NCBI]
|
1.97433e-05
|
|
|
PEPC
|
[NCBI]
|
1.97433e-05
|
|
|
INHA
|
[NCBI]
|
1.97433e-05
|
|
|
HESX1
|
[NCBI]
|
1.97433e-05
|
|
|
PKP1
|
[NCBI]
|
1.97433e-05
|
|
|
CYP27A1
|
[NCBI]
|
1.97433e-05
|
|
|
ATP2B2
|
[NCBI]
|
1.97433e-05
|
|
|
GSS
|
[NCBI]
|
1.97433e-05
|
|
|
HADH
|
[NCBI]
|
1.97433e-05
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
1.95157e-05
|
|
|
porphyria, congenital erythropoietic
|
[NCBI]
|
1.94629e-05
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
1.94629e-05
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
1.94629e-05
|
|
|
masa syndrome
|
[NCBI]
|
1.94629e-05
|
|
|
EL1
|
[NCBI]
|
1.94629e-05
|
|
|
C1NH
|
[NCBI]
|
1.93537e-05
|
|
|
SMPD1
|
[NCBI]
|
1.93537e-05
|
|
|
APEX
|
[NCBI]
|
1.93537e-05
|
|
|
ARSB
|
[NCBI]
|
1.93537e-05
|
|
|
PRSS1
|
[NCBI]
|
1.93537e-05
|
|
|
CD2AP
|
[NCBI]
|
1.93537e-05
|
|
|
GPI
|
[NCBI]
|
1.90866e-05
|
|
|
TP73L
|
[NCBI]
|
1.88276e-05
|
|
|
TCOF
|
[NCBI]
|
1.87665e-05
|
|
|
BWS
|
[NCBI]
|
1.8754e-05
|
|
|
ARG1
|
[NCBI]
|
1.86957e-05
|
|
|
MLC1
|
[NCBI]
|
1.86957e-05
|
|
|
PAX9
|
[NCBI]
|
1.86957e-05
|
|
|
FLCN
|
[NCBI]
|
1.86957e-05
|
|
|
C10ORF2
|
[NCBI]
|
1.86957e-05
|
|
|
AIS
|
[NCBI]
|
1.86744e-05
|
|
|
ABCC8
|
[NCBI]
|
1.86455e-05
|
|
|
growth hormone insensitivity syndrome
|
[NCBI]
|
1.85398e-05
|
|
|
MYH7
|
[NCBI]
|
1.85312e-05
|
|
|
PPARG
|
[NCBI]
|
1.84289e-05
|
|
|
EDN3
|
[NCBI]
|
1.8322e-05
|
|
|
CAV3
|
[NCBI]
|
1.8322e-05
|
|
|
BMP4
|
[NCBI]
|
1.8215e-05
|
|
|
mental retardation, fra12a type
|
[NCBI]
|
1.80982e-05
|
|
|
STHAG1
|
[NCBI]
|
1.80982e-05
|
|
|
neural tube defects, x-linked
|
[NCBI]
|
1.80982e-05
|
|
|
ADCC
|
[NCBI]
|
1.80982e-05
|
|
|
methylmalonic aciduria, cbla type
|
[NCBI]
|
1.80982e-05
|
|
|
peroxidase and phospholipid deficiency in eosinophils
|
[NCBI]
|
1.80982e-05
|
|
|
ectopia lentis, isolated
|
[NCBI]
|
1.80982e-05
|
|
|
OCA4
|
[NCBI]
|
1.80982e-05
|
|
|
osseous heteroplasia, progressive
|
[NCBI]
|
1.80982e-05
|
|
|
CCM2
|
[NCBI]
|
1.80982e-05
|
|
|
SMDP2
|
[NCBI]
|
1.80982e-05
|
|
|
DFNA11
|
[NCBI]
|
1.80982e-05
|
|
|
hemoglobin--variants for which the chain carrying the mutation is unknown or uncertain
|
[NCBI]
|
1.80982e-05
|
|
|
l-2-hydroxyglutaric aciduria
|
[NCBI]
|
1.80982e-05
|
|
|
DFNB18
|
[NCBI]
|
1.80982e-05
|
|
|
CMD1E
|
[NCBI]
|
1.80982e-05
|
|
|
HPE4
|
[NCBI]
|
1.80982e-05
|
|
|
gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to
|
[NCBI]
|
1.80982e-05
|
|
|
glaucoma, normal tension, susceptibility to
|
[NCBI]
|
1.80982e-05
|
|
|
naxos disease
|
[NCBI]
|
1.80982e-05
|
|
|
ectodermal dysplasia/skin fragility syndrome
|
[NCBI]
|
1.80982e-05
|
|
|
corticosterone methyloxidase type i deficiency
|
[NCBI]
|
1.80982e-05
|
|
|
PVOD
|
[NCBI]
|
1.80982e-05
|
|
|
CMRD
|
[NCBI]
|
1.80982e-05
|
|
|
azoospermia due to perturbations of meiosis
|
[NCBI]
|
1.80982e-05
|
|
|
myotonia, potassium-aggravated
|
[NCBI]
|
1.80982e-05
|
|
|
myopathy, centronuclear, autosomal dominant
|
[NCBI]
|
1.80982e-05
|
|
|
histidinemia
|
[NCBI]
|
1.80555e-05
|
|
|
NHS
|
[NCBI]
|
1.80555e-05
|
|
|
mismatch repair cancer syndrome
|
[NCBI]
|
1.80555e-05
|
|
|
REN
|
[NCBI]
|
1.78607e-05
|
|
|
ALPL
|
[NCBI]
|
1.78357e-05
|
|
|
GCH1
|
[NCBI]
|
1.78357e-05
|
|
|
F13B
|
[NCBI]
|
1.77477e-05
|
|
|
SOD1
|
[NCBI]
|
1.77179e-05
|
|
|
FRDA
|
[NCBI]
|
1.76583e-05
|
|
|
FRAP1
|
[NCBI]
|
1.75491e-05
|
|
|
TYMS
|
[NCBI]
|
1.74221e-05
|
|
|
PCD
|
[NCBI]
|
1.73984e-05
|
|
|
DWS
|
[NCBI]
|
1.73984e-05
|
|
|
TERC
|
[NCBI]
|
1.73675e-05
|
|
|
RECQL3
|
[NCBI]
|
1.73675e-05
|
|
|
NIDDM
|
[NCBI]
|
1.73006e-05
|
|
|
TP53
|
[NCBI]
|
1.72119e-05
|
|
|
KCNQ1
|
[NCBI]
|
1.69093e-05
|
|
|
SFTPC
|
[NCBI]
|
1.68832e-05
|
|
|
IKBKAP
|
[NCBI]
|
1.68832e-05
|
|
|
ATP1A1
|
[NCBI]
|
1.68832e-05
|
|
|
XG
|
[NCBI]
|
1.68832e-05
|
|
|
ABCB4
|
[NCBI]
|
1.68832e-05
|
|
|
MED12
|
[NCBI]
|
1.68832e-05
|
|
|
CDX2
|
[NCBI]
|
1.68832e-05
|
|
|
DUOX2
|
[NCBI]
|
1.68832e-05
|
|
|
FLNB
|
[NCBI]
|
1.68832e-05
|
|
|
RAI1
|
[NCBI]
|
1.68832e-05
|
|
|
LOH11CR2A
|
[NCBI]
|
1.6823e-05
|
|
|
CCDC28B
|
[NCBI]
|
1.6823e-05
|
|
|
EP400
|
[NCBI]
|
1.6823e-05
|
|
|
UNC13A
|
[NCBI]
|
1.6823e-05
|
|
|
CHD5
|
[NCBI]
|
1.6823e-05
|
|
|
DIP2B
|
[NCBI]
|
1.6823e-05
|
|
|
ZIC4
|
[NCBI]
|
1.6823e-05
|
|
|
minisatellite 33.6
|
[NCBI]
|
1.6823e-05
|
|
|
minisatellite 33.15
|
[NCBI]
|
1.6823e-05
|
|
|
KIF21A
|
[NCBI]
|
1.6823e-05
|
|
|
CTPP4
|
[NCBI]
|
1.6823e-05
|
|
|
TMEM142C
|
[NCBI]
|
1.6823e-05
|
|
|
TMEM142B
|
[NCBI]
|
1.6823e-05
|
|
|
u2 small nuclear ribonucleoprotein auxiliary factor, small subunit 2
|
[NCBI]
|
1.6823e-05
|
|
|
KRTHB3
|
[NCBI]
|
1.6823e-05
|
|
|
ZSCAN20
|
[NCBI]
|
1.6823e-05
|
|
|
GAS2L1
|
[NCBI]
|
1.6823e-05
|
|
|
PDGFRL
|
[NCBI]
|
1.6823e-05
|
|
|
TAS2R38
|
[NCBI]
|
1.6823e-05
|
|
|
pin2-interacting protein 1
|
[NCBI]
|
1.6823e-05
|
|
|
ZNF674
|
[NCBI]
|
1.6823e-05
|
|
|
ZFP37
|
[NCBI]
|
1.6823e-05
|
|
|
gpi deacylase
|
[NCBI]
|
1.6823e-05
|
|
|
DIP2C
|
[NCBI]
|
1.6823e-05
|
|
|
U2AF1RS3
|
[NCBI]
|
1.6823e-05
|
|
|
STAT3
|
[NCBI]
|
1.67906e-05
|
|
|
faciogenital dysplasia
|
[NCBI]
|
1.67486e-05
|
|
|
thrombocythemia, essential
|
[NCBI]
|
1.67486e-05
|
|
|
long-chain 3-hydroxyacyl-coa dehydrogenase deficiency
|
[NCBI]
|
1.67486e-05
|
|
|
RTD
|
[NCBI]
|
1.67486e-05
|
|
|
sialuria, finnish type
|
[NCBI]
|
1.67486e-05
|
|
|
ehlers-danlos syndrome, type i
|
[NCBI]
|
1.67486e-05
|
|
|
BMD
|
[NCBI]
|
1.67144e-05
|
|
|
HGPS
|
[NCBI]
|
1.66027e-05
|
|
|
GLB1
|
[NCBI]
|
1.64807e-05
|
|
|
PPOX
|
[NCBI]
|
1.64807e-05
|
|
|
FMO3
|
[NCBI]
|
1.64807e-05
|
|
|
PEPD
|
[NCBI]
|
1.64807e-05
|
|
|
FGFR2
|
[NCBI]
|
1.64123e-05
|
|
|
FUT1
|
[NCBI]
|
1.60898e-05
|
|
|
3-@hydroxy-3-methylglutaryl-coa lyase deficiency
|
[NCBI]
|
1.60898e-05
|
|
|
S100A8
|
[NCBI]
|
1.60898e-05
|
|
|
PCSK9
|
[NCBI]
|
1.60898e-05
|
|
|
SALL1
|
[NCBI]
|
1.60898e-05
|
|
|
PCCA
|
[NCBI]
|
1.60898e-05
|
|
|
HIC1
|
[NCBI]
|
1.60898e-05
|
|
|
NOTCH3
|
[NCBI]
|
1.60898e-05
|
|
|
BTD
|
[NCBI]
|
1.60898e-05
|
|
|
GDF5
|
[NCBI]
|
1.60604e-05
|
|
|
GHRL
|
[NCBI]
|
1.60604e-05
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
1.60604e-05
|
|
|
PSEN1
|
[NCBI]
|
1.59247e-05
|
|
|
RASA1
|
[NCBI]
|
1.57614e-05
|
|
|
IRS1
|
[NCBI]
|
1.57327e-05
|
|
|
ABCC6
|
[NCBI]
|
1.56542e-05
|
|
|
AVPR2
|
[NCBI]
|
1.56542e-05
|
|
|
coproporphyria
|
[NCBI]
|
1.56542e-05
|
|
|
MLC
|
[NCBI]
|
1.5533e-05
|
|
|
EKV
|
[NCBI]
|
1.5533e-05
|
|
|
MADA
|
[NCBI]
|
1.5533e-05
|
|
|
niemann-pick disease, type a
|
[NCBI]
|
1.5533e-05
|
|
|
hand-foot-uterus syndrome
|
[NCBI]
|
1.53933e-05
|
|
|
FMO2
|
[NCBI]
|
1.53933e-05
|
|
|
vater association
|
[NCBI]
|
1.53933e-05
|
|
|
cardiomyopathy, familial hypertrophic, with wolff-parkinson-white syndrome
|
[NCBI]
|
1.53933e-05
|
|
|
F5F8D
|
[NCBI]
|
1.53933e-05
|
|
|
legg-calve-perthes disease
|
[NCBI]
|
1.53933e-05
|
|
|
short stature, idiopathic, autosomal
|
[NCBI]
|
1.53933e-05
|
|
|
CDG1C
|
[NCBI]
|
1.53933e-05
|
|
|
methylcobalamin deficiency, cblg type
|
[NCBI]
|
1.53933e-05
|
|
|
ichthyosis, bullous type
|
[NCBI]
|
1.53933e-05
|
|
|
FHL2
|
[NCBI]
|
1.53933e-05
|
|
|
LGMD2J
|
[NCBI]
|
1.53933e-05
|
|
|
LGMD1C
|
[NCBI]
|
1.53933e-05
|
|
|
avascular necrosis of femoral head, primary
|
[NCBI]
|
1.53933e-05
|
|
|
cardiomyopathy, dilated, with woolly hair and keratoderma
|
[NCBI]
|
1.53933e-05
|
|
|
PC1
|
[NCBI]
|
1.53933e-05
|
|
|
CCM3
|
[NCBI]
|
1.53933e-05
|
|
|
AOII
|
[NCBI]
|
1.53933e-05
|
|
|
lujan-fryns syndrome
|
[NCBI]
|
1.53933e-05
|
|
|
EAD
|
[NCBI]
|
1.53933e-05
|
|
|
endometrial cancer
|
[NCBI]
|
1.53933e-05
|
|
|
ehlers-danlos syndrome, progeroid form
|
[NCBI]
|
1.53933e-05
|
|
|
deafness, congenital, with keratopachydermia and constrictions of fingers and toes
|
[NCBI]
|
1.53933e-05
|
|
|
aplastic anemia
|
[NCBI]
|
1.53933e-05
|
|
|
vacterl association with hydrocephalus
|
[NCBI]
|
1.53933e-05
|
|
|
WT5
|
[NCBI]
|
1.53933e-05
|
|
|
AGL
|
[NCBI]
|
1.53575e-05
|
|
|
PKHD1
|
[NCBI]
|
1.53575e-05
|
|
|
SLC1A3
|
[NCBI]
|
1.53575e-05
|
|
|
TNFRSF11A
|
[NCBI]
|
1.53575e-05
|
|
|
INVS
|
[NCBI]
|
1.53575e-05
|
|
|
ME2
|
[NCBI]
|
1.53575e-05
|
|
|
FOXP2
|
[NCBI]
|
1.53575e-05
|
|
|
LPI
|
[NCBI]
|
1.5273e-05
|
|
|
PF4
|
[NCBI]
|
1.5268e-05
|
|
|
ACADS
|
[NCBI]
|
1.52615e-05
|
|
|
glycogen storage disease i
|
[NCBI]
|
1.52615e-05
|
|
|
FGG
|
[NCBI]
|
1.52615e-05
|
|
|
FANCA
|
[NCBI]
|
1.52615e-05
|
|
|
XPA
|
[NCBI]
|
1.50435e-05
|
|
|
JPS
|
[NCBI]
|
1.50435e-05
|
|
|
FANCC
|
[NCBI]
|
1.48815e-05
|
|
|
RUNX2
|
[NCBI]
|
1.48815e-05
|
|
|
RECQL2
|
[NCBI]
|
1.48815e-05
|
|
|
PTPRC
|
[NCBI]
|
1.48815e-05
|
|
|
ABO
|
[NCBI]
|
1.48815e-05
|
|
|
MAS
|
[NCBI]
|
1.47011e-05
|
|
|
CAMK2A
|
[NCBI]
|
1.46784e-05
|
|
|
ELAC2
|
[NCBI]
|
1.46784e-05
|
|
|
SLC26A2
|
[NCBI]
|
1.46784e-05
|
|
|
PCSK1
|
[NCBI]
|
1.46784e-05
|
|
|
SCARB1
|
[NCBI]
|
1.46784e-05
|
|
|
IRF6
|
[NCBI]
|
1.46784e-05
|
|
|
CYP2C9
|
[NCBI]
|
1.46784e-05
|
|
|
RAPSN
|
[NCBI]
|
1.46784e-05
|
|
|
COL5A1
|
[NCBI]
|
1.46784e-05
|
|
|
TG
|
[NCBI]
|
1.463e-05
|
|
|
EDNRB
|
[NCBI]
|
1.45135e-05
|
|
|
hyperglycerolemia
|
[NCBI]
|
1.44003e-05
|
|
|
HOKPP
|
[NCBI]
|
1.44003e-05
|
|
|
TYR
|
[NCBI]
|
1.4317e-05
|
|
|
ATP7B
|
[NCBI]
|
1.4157e-05
|
|
|
DES
|
[NCBI]
|
1.4157e-05
|
|
|
ABCD1
|
[NCBI]
|
1.41391e-05
|
|
|
SLC6A3
|
[NCBI]
|
1.40492e-05
|
|
|
TBX1
|
[NCBI]
|
1.40462e-05
|
|
|
TAZ
|
[NCBI]
|
1.40462e-05
|
|
|
SCNN1B
|
[NCBI]
|
1.40462e-05
|
|
|
CYP11A1
|
[NCBI]
|
1.40462e-05
|
|
|
FGB
|
[NCBI]
|
1.40462e-05
|
|
|
STAR
|
[NCBI]
|
1.40195e-05
|
|
|
GAA
|
[NCBI]
|
1.38115e-05
|
|
|
PSAT1
|
[NCBI]
|
1.38e-05
|
|
|
ATP2B4
|
[NCBI]
|
1.38e-05
|
|
|
PHYHIP
|
[NCBI]
|
1.38e-05
|
|
|
CHST5
|
[NCBI]
|
1.38e-05
|
|
|
NEUROD4
|
[NCBI]
|
1.38e-05
|
|
|
E2F5
|
[NCBI]
|
1.38e-05
|
|
|
TRRAP
|
[NCBI]
|
1.38e-05
|
|
|
neurochondrin
|
[NCBI]
|
1.38e-05
|
|
|
DNAI1
|
[NCBI]
|
1.38e-05
|
|
|
CHFR
|
[NCBI]
|
1.38e-05
|
|
|
ZNF200
|
[NCBI]
|
1.38e-05
|
|
|
oncogene ovc
|
[NCBI]
|
1.38e-05
|
|
|
deleted in endometrial carcinoma
|
[NCBI]
|
1.38e-05
|
|
|
ZNF169
|
[NCBI]
|
1.38e-05
|
|
|
DIP2A
|
[NCBI]
|
1.38e-05
|
|
|
GSTM5
|
[NCBI]
|
1.38e-05
|
|
|
EPHB4
|
[NCBI]
|
1.38e-05
|
|
|
SLC24A5
|
[NCBI]
|
1.38e-05
|
|
|
ACAD8
|
[NCBI]
|
1.38e-05
|
|
|
ETFDH
|
[NCBI]
|
1.38e-05
|
|
|
MTL5
|
[NCBI]
|
1.38e-05
|
|
|
TULP3
|
[NCBI]
|
1.38e-05
|
|
|
MKS1
|
[NCBI]
|
1.38e-05
|
|
|
CAPN5
|
[NCBI]
|
1.38e-05
|
|
|
CA10
|
[NCBI]
|
1.38e-05
|
|
|
u2 small nuclear ribonucleoprotein auxiliary factor, small subunit 1
|
[NCBI]
|
1.38e-05
|
|
|
MTHFD1L
|
[NCBI]
|
1.38e-05
|
|
|
CYLN2
|
[NCBI]
|
1.38e-05
|
|
|
PTPRM
|
[NCBI]
|
1.38e-05
|
|
|
FOXH1
|
[NCBI]
|
1.38e-05
|
|
|
SH3BP2
|
[NCBI]
|
1.38e-05
|
|
|
HSF2
|
[NCBI]
|
1.38e-05
|
|
|
KCNJ13
|
[NCBI]
|
1.38e-05
|
|
|
COX17
|
[NCBI]
|
1.38e-05
|
|
|
MAEA
|
[NCBI]
|
1.38e-05
|
|
|
EXT2
|
[NCBI]
|
1.34553e-05
|
|
|
JK
|
[NCBI]
|
1.34553e-05
|
|
|
ITGB4
|
[NCBI]
|
1.34553e-05
|
|
|
FOXC1
|
[NCBI]
|
1.34553e-05
|
|
|
GLRA1
|
[NCBI]
|
1.34553e-05
|
|
|
GLDC
|
[NCBI]
|
1.34553e-05
|
|
|
CNTF
|
[NCBI]
|
1.34391e-05
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
1.34335e-05
|
|
|
citrullinemia, classic
|
[NCBI]
|
1.33437e-05
|
|
|
PDB
|
[NCBI]
|
1.33437e-05
|
|
|
ODDD
|
[NCBI]
|
1.33437e-05
|
|
|
TLR4
|
[NCBI]
|
1.32117e-05
|
|
|
opitz syndrome
|
[NCBI]
|
1.31712e-05
|
|
|
mast cell disease
|
[NCBI]
|
1.31712e-05
|
|
|
PGL4
|
[NCBI]
|
1.31712e-05
|
|
|
AOI
|
[NCBI]
|
1.31712e-05
|
|
|
kuru, susceptibility to
|
[NCBI]
|
1.31712e-05
|
|
|
aceruloplasminemia
|
[NCBI]
|
1.31712e-05
|
|
|
GLYS1
|
[NCBI]
|
1.31712e-05
|
|
|
proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis
|
[NCBI]
|
1.31712e-05
|
|
|
cystathioninuria
|
[NCBI]
|
1.31712e-05
|
|
|
citrullinemia, type ii, neonatal-onset
|
[NCBI]
|
1.31712e-05
|
|
|
MFS2
|
[NCBI]
|
1.31712e-05
|
|
|
IBM3
|
[NCBI]
|
1.31712e-05
|
|
|
colorectal adenomatous polyposis, autosomal recessive
|
[NCBI]
|
1.31712e-05
|
|
|
cryptorchidism, unilateral or bilateral
|
[NCBI]
|
1.31712e-05
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
1.31712e-05
|
|
|
ehlers-danlos syndrome, type vii, autosomal recessive
|
[NCBI]
|
1.31712e-05
|
|
|
SMAX1
|
[NCBI]
|
1.31052e-05
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
1.30797e-05
|
|
|
JMML
|
[NCBI]
|
1.30705e-05
|
|
|
NR4A2
|
[NCBI]
|
1.29013e-05
|
|
|
PGM3
|
[NCBI]
|
1.29013e-05
|
|
|
PTPN22
|
[NCBI]
|
1.29013e-05
|
|
|
FUT2
|
[NCBI]
|
1.29013e-05
|
|
|
FOXL2
|
[NCBI]
|
1.29013e-05
|
|
|
GUCY2D
|
[NCBI]
|
1.29013e-05
|
|
|
EP300
|
[NCBI]
|
1.29013e-05
|
|
|
HMBS
|
[NCBI]
|
1.26741e-05
|
|
|
RUNX1
|
[NCBI]
|
1.25282e-05
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
1.23804e-05
|
|
|
DHCR7
|
[NCBI]
|
1.23804e-05
|
|
|
SFTPB
|
[NCBI]
|
1.23804e-05
|
|
|
CSF1
|
[NCBI]
|
1.23804e-05
|
|
|
LCP1
|
[NCBI]
|
1.23804e-05
|
|
|
lung cancer
|
[NCBI]
|
1.23568e-05
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
1.23568e-05
|
|
|
RELN
|
[NCBI]
|
1.223e-05
|
|
|
AR
|
[NCBI]
|
1.21801e-05
|
|
|
BBS
|
[NCBI]
|
1.20769e-05
|
|
|
SLC11A2
|
[NCBI]
|
1.20694e-05
|
|
|
ABCA1
|
[NCBI]
|
1.19401e-05
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
1.19401e-05
|
|
|
CTSC
|
[NCBI]
|
1.19401e-05
|
|
|
GJB6
|
[NCBI]
|
1.18893e-05
|
|
|
DSP
|
[NCBI]
|
1.18893e-05
|
|
|
CRYZ
|
[NCBI]
|
1.18684e-05
|
|
|
SLC34A3
|
[NCBI]
|
1.18684e-05
|
|
|
LIPH
|
[NCBI]
|
1.18684e-05
|
|
|
TBX10
|
[NCBI]
|
1.18684e-05
|
|
|
RASGRF2
|
[NCBI]
|
1.18684e-05
|
|
|
ZNF202
|
[NCBI]
|
1.18684e-05
|
|
|
GUCY2F
|
[NCBI]
|
1.18684e-05
|
|
|
GCS1
|
[NCBI]
|
1.18684e-05
|
|
|
TBX6
|
[NCBI]
|
1.18684e-05
|
|
|
NELF
|
[NCBI]
|
1.18684e-05
|
|
|
SOSTDC1
|
[NCBI]
|
1.18684e-05
|
|
|
CPEB1
|
[NCBI]
|
1.18684e-05
|
|
|
L2HGDH
|
[NCBI]
|
1.18684e-05
|
|
|
FIGN
|
[NCBI]
|
1.18684e-05
|
|
|
FAM123B
|
[NCBI]
|
1.18684e-05
|
|
|
ATBF1
|
[NCBI]
|
1.18684e-05
|
|
|
IRX5
|
[NCBI]
|
1.18684e-05
|
|
|
CRELD1
|
[NCBI]
|
1.18684e-05
|
|
|
PLEKHG4
|
[NCBI]
|
1.18684e-05
|
|
|
ACTN2
|
[NCBI]
|
1.18684e-05
|
|
|
FEZF2
|
[NCBI]
|
1.18684e-05
|
|
|
POLG2
|
[NCBI]
|
1.18684e-05
|
|
|
ZIC1
|
[NCBI]
|
1.18684e-05
|
|
|
SCN7A
|
[NCBI]
|
1.18684e-05
|
|
|
HPS3
|
[NCBI]
|
1.18684e-05
|
|
|
CANX
|
[NCBI]
|
1.18684e-05
|
|
|
PAXIP1
|
[NCBI]
|
1.18684e-05
|
|
|
IGKV1OR2108
|
[NCBI]
|
1.18684e-05
|
|
|
ALDH7A1
|
[NCBI]
|
1.18684e-05
|
|
|
MUS81
|
[NCBI]
|
1.18684e-05
|
|
|
CYP26A1
|
[NCBI]
|
1.18684e-05
|
|
|
ORC3L
|
[NCBI]
|
1.18684e-05
|
|
|
NR1I2
|
[NCBI]
|
1.16083e-05
|
|
|
glioma of brain, familial
|
[NCBI]
|
1.14515e-05
|
|
|
MC2R
|
[NCBI]
|
1.14254e-05
|
|
|
MPL
|
[NCBI]
|
1.14254e-05
|
|
|
GHRHR
|
[NCBI]
|
1.14254e-05
|
|
|
ADAMTS13
|
[NCBI]
|
1.14254e-05
|
|
|
AMPD1
|
[NCBI]
|
1.14254e-05
|
|
|
FOXC2
|
[NCBI]
|
1.14254e-05
|
|
|
F12
|
[NCBI]
|
1.14254e-05
|
|
|
WBS
|
[NCBI]
|
1.13787e-05
|
|
|
arbitrary restriction polymorphism 1
|
[NCBI]
|
1.13102e-05
|
|
|
GGM
|
[NCBI]
|
1.13102e-05
|
|
|
fundus albipunctatus
|
[NCBI]
|
1.13102e-05
|
|
|
RMS1
|
[NCBI]
|
1.13102e-05
|
|
|
gitelman syndrome
|
[NCBI]
|
1.13102e-05
|
|
|
OCA3
|
[NCBI]
|
1.13102e-05
|
|
|
growth hormone insensitivity with immunodeficiency
|
[NCBI]
|
1.13102e-05
|
|
|
IHCM
|
[NCBI]
|
1.13102e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2
|
[NCBI]
|
1.13102e-05
|
|
|
HPP
|
[NCBI]
|
1.13102e-05
|
|
|
ehlers-danlos syndrome, type vii, autosomal dominant
|
[NCBI]
|
1.13102e-05
|
|
|
morquio syndrome b
|
[NCBI]
|
1.13102e-05
|
|
|
NSHPT
|
[NCBI]
|
1.13102e-05
|
|
|
alpha-methylacetoacetic aciduria
|
[NCBI]
|
1.13102e-05
|
|
|
DFNA3
|
[NCBI]
|
1.13102e-05
|
|
|
FTC
|
[NCBI]
|
1.13102e-05
|
|
|
RP12
|
[NCBI]
|
1.13102e-05
|
|
|
polydactyly, postaxial, type a1
|
[NCBI]
|
1.13102e-05
|
|
|
DDD
|
[NCBI]
|
1.13102e-05
|
|
|
LRS1
|
[NCBI]
|
1.13102e-05
|
|
|
RHN
|
[NCBI]
|
1.13102e-05
|
|
|
sc phocomelia syndrome
|
[NCBI]
|
1.13102e-05
|
|
|
HHF6
|
[NCBI]
|
1.13102e-05
|
|
|
AML
|
[NCBI]
|
1.13102e-05
|
|
|
SCA12
|
[NCBI]
|
1.13102e-05
|
|
|
3-@methylglutaconic aciduria, type i
|
[NCBI]
|
1.13102e-05
|
|
|
XPB
|
[NCBI]
|
1.13102e-05
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
1.11508e-05
|
|
|
CFH
|
[NCBI]
|
1.11222e-05
|
|
|
krabbe disease
|
[NCBI]
|
1.11092e-05
|
|
|
NKX2-1
|
[NCBI]
|
1.0986e-05
|
|
|
AACT
|
[NCBI]
|
1.0986e-05
|
|
|
GJB3
|
[NCBI]
|
1.0986e-05
|
|
|
WFS1
|
[NCBI]
|
1.0986e-05
|
|
|
DMD
|
[NCBI]
|
1.0893e-05
|
|
|
obesity
|
[NCBI]
|
1.08219e-05
|
|
|
MFS
|
[NCBI]
|
1.07814e-05
|
|
|
SCN5A
|
[NCBI]
|
1.0603e-05
|
|
|
ACP5
|
[NCBI]
|
1.05747e-05
|
|
|
SPDA1
|
[NCBI]
|
1.05709e-05
|
|
|
BOR1
|
[NCBI]
|
1.05709e-05
|
|
|
POF1
|
[NCBI]
|
1.05709e-05
|
|
|
UROS
|
[NCBI]
|
1.05693e-05
|
|
|
HNF1B
|
[NCBI]
|
1.05693e-05
|
|
|
B4GALT7
|
[NCBI]
|
1.04551e-05
|
|
|
VN1R1
|
[NCBI]
|
1.04551e-05
|
|
|
PRSS7
|
[NCBI]
|
1.04551e-05
|
|
|
MAP3K13
|
[NCBI]
|
1.04551e-05
|
|
|
A1BG
|
[NCBI]
|
1.04551e-05
|
|
|
DRAP1
|
[NCBI]
|
1.04551e-05
|
|
|
SLC5A2
|
[NCBI]
|
1.04551e-05
|
|
|
ACADSB
|
[NCBI]
|
1.04551e-05
|
|
|
ESX1L
|
[NCBI]
|
1.04551e-05
|
|
|
PHF6
|
[NCBI]
|
1.04551e-05
|
|
|
ABAT
|
[NCBI]
|
1.04551e-05
|
|
|
BAIAP1
|
[NCBI]
|
1.04551e-05
|
|
|
SENP2
|
[NCBI]
|
1.04551e-05
|
|
|
CSNK1E
|
[NCBI]
|
1.04551e-05
|
|
|
GLRB
|
[NCBI]
|
1.04551e-05
|
|
|
EIF2AK4
|
[NCBI]
|
1.04551e-05
|
|
|
ESPL1
|
[NCBI]
|
1.04551e-05
|
|
|
NPR2
|
[NCBI]
|
1.04551e-05
|
|
|
PTGER1
|
[NCBI]
|
1.04551e-05
|
|
|
MMP20
|
[NCBI]
|
1.04551e-05
|
|
|
YARS
|
[NCBI]
|
1.04551e-05
|
|
|
ADRA2B
|
[NCBI]
|
1.04551e-05
|
|
|
GDF9
|
[NCBI]
|
1.04551e-05
|
|
|
OSTM1
|
[NCBI]
|
1.04551e-05
|
|
|
MYOG
|
[NCBI]
|
1.04551e-05
|
|
|
HSPA6
|
[NCBI]
|
1.04551e-05
|
|
|
NBL1
|
[NCBI]
|
1.04551e-05
|
|
|
RGR
|
[NCBI]
|
1.04551e-05
|
|
|
BCAP31
|
[NCBI]
|
1.04551e-05
|
|
|
TXN2
|
[NCBI]
|
1.04551e-05
|
|
|
SIM1
|
[NCBI]
|
1.04551e-05
|
|
|
FOXI1
|
[NCBI]
|
1.04551e-05
|
|
|
PIP5K1B
|
[NCBI]
|
1.04551e-05
|
|
|
ITGA6
|
[NCBI]
|
1.04551e-05
|
|
|
UBE2A
|
[NCBI]
|
1.04551e-05
|
|
|
EPX
|
[NCBI]
|
1.04551e-05
|
|
|
CRKL
|
[NCBI]
|
1.04551e-05
|
|
|
PHLDA2
|
[NCBI]
|
1.04551e-05
|
|
|
ADM
|
[NCBI]
|
1.03632e-05
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
1.02532e-05
|
|
|
MHS1
|
[NCBI]
|
1.02189e-05
|
|
|
PROCR
|
[NCBI]
|
1.01154e-05
|
|
|
BTK
|
[NCBI]
|
9.95586e-06
|
|
|
KIT
|
[NCBI]
|
9.88076e-06
|
|
|
KCNA1
|
[NCBI]
|
9.79631e-06
|
|
|
PMS2
|
[NCBI]
|
9.79631e-06
|
|
|
SCN1A
|
[NCBI]
|
9.79631e-06
|
|
|
MTM1
|
[NCBI]
|
9.79631e-06
|
|
|
STGD1
|
[NCBI]
|
9.76283e-06
|
|
|
RP1
|
[NCBI]
|
9.76283e-06
|
|
|
POMC
|
[NCBI]
|
9.73293e-06
|
|
|
17-@beta hydroxysteroid dehydrogenase iii deficiency
|
[NCBI]
|
9.72937e-06
|
|
|
LISX1
|
[NCBI]
|
9.72937e-06
|
|
|
ATLD
|
[NCBI]
|
9.72937e-06
|
|
|
argininemia
|
[NCBI]
|
9.72937e-06
|
|
|
corneal dystrophy, gelatinous drop-like
|
[NCBI]
|
9.72937e-06
|
|
|
WZS
|
[NCBI]
|
9.72937e-06
|
|
|
muenke syndrome
|
[NCBI]
|
9.72937e-06
|
|
|
CZP1
|
[NCBI]
|
9.72937e-06
|
|
|
hypouricemia, renal
|
[NCBI]
|
9.72937e-06
|
|
|
hyperostosis corticalis generalisata
|
[NCBI]
|
9.72937e-06
|
|
|
spinocerebellar ataxia, 16q22-linked
|
[NCBI]
|
9.72937e-06
|
|
|
PKD3
|
[NCBI]
|
9.72937e-06
|
|
|
MCPH5
|
[NCBI]
|
9.72937e-06
|
|
|
situs inversus viscerum
|
[NCBI]
|
9.72937e-06
|
|
|
monosomy 7 of bone marrow
|
[NCBI]
|
9.72937e-06
|
|
|
gaucher disease, perinatal lethal
|
[NCBI]
|
9.72937e-06
|
|
|
ankyloblepharon-ectodermal defects-cleft lip/palate
|
[NCBI]
|
9.72937e-06
|
|
|
WS1
|
[NCBI]
|
9.64154e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
9.4854e-06
|
|
|
PTPN1
|
[NCBI]
|
9.437e-06
|
|
|
GJA5
|
[NCBI]
|
9.437e-06
|
|
|
MVK
|
[NCBI]
|
9.437e-06
|
|
|
NAT1
|
[NCBI]
|
9.42866e-06
|
|
|
DCC
|
[NCBI]
|
9.42866e-06
|
|
|
BCHE
|
[NCBI]
|
9.40011e-06
|
|
|
GDA
|
[NCBI]
|
9.34717e-06
|
|
|
PLOD3
|
[NCBI]
|
9.34717e-06
|
|
|
GCM1
|
[NCBI]
|
9.34717e-06
|
|
|
HOXD12
|
[NCBI]
|
9.34717e-06
|
|
|
GNB5
|
[NCBI]
|
9.34717e-06
|
|
|
KCNK2
|
[NCBI]
|
9.34717e-06
|
|
|
RNF139
|
[NCBI]
|
9.34717e-06
|
|
|
NPHP3
|
[NCBI]
|
9.34717e-06
|
|
|
CHE2
|
[NCBI]
|
9.34717e-06
|
|
|
precursor mrna-processing factor 3, s. cerevisiae, homolog of
|
[NCBI]
|
9.34717e-06
|
|
|
SLC9A3
|
[NCBI]
|
9.34717e-06
|
|
|
AVPR1B
|
[NCBI]
|
9.34717e-06
|
|
|
RBBP9
|
[NCBI]
|
9.34717e-06
|
|
|
GNA13
|
[NCBI]
|
9.34717e-06
|
|
|
HOXD11
|
[NCBI]
|
9.34717e-06
|
|
|
TMEM142A
|
[NCBI]
|
9.34717e-06
|
|
|
LALBA
|
[NCBI]
|
9.34717e-06
|
|
|
ANK2
|
[NCBI]
|
9.34717e-06
|
|
|
OPCML
|
[NCBI]
|
9.34717e-06
|
|
|
TWIST2
|
[NCBI]
|
9.34717e-06
|
|
|
NLGN4
|
[NCBI]
|
9.34717e-06
|
|
|
HSD17B3
|
[NCBI]
|
9.34717e-06
|
|
|
UBE2N
|
[NCBI]
|
9.34717e-06
|
|
|
TROVE2
|
[NCBI]
|
9.34717e-06
|
|
|
TALDO1
|
[NCBI]
|
9.34717e-06
|
|
|
DACH1
|
[NCBI]
|
9.34717e-06
|
|
|
ZNF384
|
[NCBI]
|
9.34717e-06
|
|
|
CNTN4
|
[NCBI]
|
9.34717e-06
|
|
|
CRMP1
|
[NCBI]
|
9.34717e-06
|
|
|
alopecia, androgenetic
|
[NCBI]
|
9.22332e-06
|
|
|
IGF2
|
[NCBI]
|
9.21081e-06
|
|
|
SLC2A2
|
[NCBI]
|
9.21081e-06
|
|
|
PROP1
|
[NCBI]
|
9.09404e-06
|
|
|
MUT
|
[NCBI]
|
9.09404e-06
|
|
|
VHL
|
[NCBI]
|
9.08206e-06
|
|
|
DKC
|
[NCBI]
|
9.00592e-06
|
|
|
OPRM1
|
[NCBI]
|
8.95942e-06
|
|
|
CPE
|
[NCBI]
|
8.80272e-06
|
|
|
IPF1
|
[NCBI]
|
8.76629e-06
|
|
|
FABP2
|
[NCBI]
|
8.76629e-06
|
|
|
TIMP1
|
[NCBI]
|
8.76629e-06
|
|
|
ARX
|
[NCBI]
|
8.76629e-06
|
|
|
AKR1B1
|
[NCBI]
|
8.74356e-06
|
|
|
NOS3
|
[NCBI]
|
8.58789e-06
|
|
|
ALDH1A2
|
[NCBI]
|
8.45272e-06
|
|
|
ETV6
|
[NCBI]
|
8.45272e-06
|
|
|
CNGA2
|
[NCBI]
|
8.44094e-06
|
|
|
LIPG
|
[NCBI]
|
8.44094e-06
|
|
|
FBXW4
|
[NCBI]
|
8.44094e-06
|
|
|
CSNK2A2
|
[NCBI]
|
8.44094e-06
|
|
|
LHX8
|
[NCBI]
|
8.44094e-06
|
|
|
ATP2B1
|
[NCBI]
|
8.44094e-06
|
|
|
HLA-DPB1
|
[NCBI]
|
8.44094e-06
|
|
|
DMP1
|
[NCBI]
|
8.44094e-06
|
|
|
SATB2
|
[NCBI]
|
8.44094e-06
|
|
|
FTO
|
[NCBI]
|
8.44094e-06
|
|
|
ALDH4A1
|
[NCBI]
|
8.44094e-06
|
|
|
HAND1
|
[NCBI]
|
8.44094e-06
|
|
|
SLURP1
|
[NCBI]
|
8.44094e-06
|
|
|
IL21
|
[NCBI]
|
8.44094e-06
|
|
|
NHLH1
|
[NCBI]
|
8.44094e-06
|
|
|
MPP1
|
[NCBI]
|
8.44094e-06
|
|
|
DLX5
|
[NCBI]
|
8.44094e-06
|
|
|
ESCO2
|
[NCBI]
|
8.44094e-06
|
|
|
KCNE3
|
[NCBI]
|
8.44094e-06
|
|
|
S100A1
|
[NCBI]
|
8.44094e-06
|
|
|
PHKG2
|
[NCBI]
|
8.44094e-06
|
|
|
KRT6A
|
[NCBI]
|
8.44094e-06
|
|
|
PPP1R3A
|
[NCBI]
|
8.44094e-06
|
|
|
GTF2I
|
[NCBI]
|
8.44094e-06
|
|
|
GAB1
|
[NCBI]
|
8.44094e-06
|
|
|
ATP2C1
|
[NCBI]
|
8.44094e-06
|
|
|
HAGH
|
[NCBI]
|
8.44094e-06
|
|
|
HOXD10
|
[NCBI]
|
8.44094e-06
|
|
|
DNMT3L
|
[NCBI]
|
8.44094e-06
|
|
|
SDC2
|
[NCBI]
|
8.41266e-06
|
|
|
NF2
|
[NCBI]
|
8.38991e-06
|
|
|
IDDM
|
[NCBI]
|
8.38771e-06
|
|
|
ASMD
|
[NCBI]
|
8.37242e-06
|
|
|
HNPCC2
|
[NCBI]
|
8.37242e-06
|
|
|
uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to
|
[NCBI]
|
8.37242e-06
|
|
|
ehlers-danlos syndrome, type ii
|
[NCBI]
|
8.37242e-06
|
|
|
DGI1
|
[NCBI]
|
8.37242e-06
|
|
|
PHA1
|
[NCBI]
|
8.37242e-06
|
|
|
XPV
|
[NCBI]
|
8.37242e-06
|
|
|
DFNA12
|
[NCBI]
|
8.37242e-06
|
|
|
BDA1
|
[NCBI]
|
8.37242e-06
|
|
|
GVM
|
[NCBI]
|
8.37242e-06
|
|
|
OSMED
|
[NCBI]
|
8.37242e-06
|
|
|
SCA14
|
[NCBI]
|
8.37242e-06
|
|
|
HTX1
|
[NCBI]
|
8.37242e-06
|
|
|
scheie syndrome
|
[NCBI]
|
8.37242e-06
|
|
|
coloboma, ocular
|
[NCBI]
|
8.37242e-06
|
|
|
RP
|
[NCBI]
|
8.33349e-06
|
|
|
FPLD2
|
[NCBI]
|
8.29676e-06
|
|
|
GH1
|
[NCBI]
|
8.20071e-06
|
|
|
CYP11B2
|
[NCBI]
|
8.15239e-06
|
|
|
IRS2
|
[NCBI]
|
8.15239e-06
|
|
|
TWIST1
|
[NCBI]
|
8.15239e-06
|
|
|
E2F1
|
[NCBI]
|
8.15239e-06
|
|
|
hurler syndrome
|
[NCBI]
|
8.05302e-06
|
|
|
MB
|
[NCBI]
|
7.96481e-06
|
|
|
IGF1R
|
[NCBI]
|
7.86446e-06
|
|
|
AK1
|
[NCBI]
|
7.86446e-06
|
|
|
COL6A1
|
[NCBI]
|
7.86446e-06
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
7.86446e-06
|
|
|
CETP
|
[NCBI]
|
7.86446e-06
|
|
|
BIRC1
|
[NCBI]
|
7.82284e-06
|
|
|
HADHB
|
[NCBI]
|
7.6781e-06
|
|
|
HLXB9
|
[NCBI]
|
7.6781e-06
|
|
|
TP53BP2
|
[NCBI]
|
7.6781e-06
|
|
|
FCGRT
|
[NCBI]
|
7.6781e-06
|
|
|
LPIN2
|
[NCBI]
|
7.6781e-06
|
|
|
TBX4
|
[NCBI]
|
7.6781e-06
|
|
|
BECN1
|
[NCBI]
|
7.6781e-06
|
|
|
PTGFR
|
[NCBI]
|
7.6781e-06
|
|
|
RENT1
|
[NCBI]
|
7.6781e-06
|
|
|
MOCS2
|
[NCBI]
|
7.6781e-06
|
|
|
cocaine- and amphetamine-regulated transcript
|
[NCBI]
|
7.6781e-06
|
|
|
ACP2
|
[NCBI]
|
7.6781e-06
|
|
|
EVC2
|
[NCBI]
|
7.6781e-06
|
|
|
E2F4
|
[NCBI]
|
7.6781e-06
|
|
|
GJC1
|
[NCBI]
|
7.6781e-06
|
|
|
FLNC
|
[NCBI]
|
7.6781e-06
|
|
|
DCLRE1C
|
[NCBI]
|
7.6781e-06
|
|
|
GCGR
|
[NCBI]
|
7.6781e-06
|
|
|
CUL4B
|
[NCBI]
|
7.6781e-06
|
|
|
COLQ
|
[NCBI]
|
7.6781e-06
|
|
|
GATA6
|
[NCBI]
|
7.6781e-06
|
|
|
SLC39A4
|
[NCBI]
|
7.6781e-06
|
|
|
CLCN2
|
[NCBI]
|
7.6781e-06
|
|
|
ROM1
|
[NCBI]
|
7.6781e-06
|
|
|
RPL7A
|
[NCBI]
|
7.6781e-06
|
|
|
COPS5
|
[NCBI]
|
7.6781e-06
|
|
|
ALX4
|
[NCBI]
|
7.6781e-06
|
|
|
SLC27A4
|
[NCBI]
|
7.6781e-06
|
|
|
GABRD
|
[NCBI]
|
7.6781e-06
|
|
|
TCF21
|
[NCBI]
|
7.6781e-06
|
|
|
tl antigen
|
[NCBI]
|
7.6781e-06
|
|
|
SLC7A7
|
[NCBI]
|
7.6781e-06
|
|
|
CBLB
|
[NCBI]
|
7.6781e-06
|
|
|
SLC25A13
|
[NCBI]
|
7.6781e-06
|
|
|
SDHA
|
[NCBI]
|
7.6781e-06
|
|
|
PSPH
|
[NCBI]
|
7.6781e-06
|
|
|
GNAT2
|
[NCBI]
|
7.6781e-06
|
|
|
complement component 8 deficiency, type ii
|
[NCBI]
|
7.6781e-06
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
7.6322e-06
|
|
|
FCHL
|
[NCBI]
|
7.6322e-06
|
|
|
DYSF
|
[NCBI]
|
7.58817e-06
|
|
|
IL12B
|
[NCBI]
|
7.58817e-06
|
|
|
COL10A1
|
[NCBI]
|
7.58817e-06
|
|
|
GUSB
|
[NCBI]
|
7.50044e-06
|
|
|
GPT
|
[NCBI]
|
7.46583e-06
|
|
|
CMT1A
|
[NCBI]
|
7.44513e-06
|
|
|
GC
|
[NCBI]
|
7.42439e-06
|
|
|
CLCN1
|
[NCBI]
|
7.32281e-06
|
|
|
CYBB
|
[NCBI]
|
7.32281e-06
|
|
|
TLR2
|
[NCBI]
|
7.30659e-06
|
|
|
MYOC
|
[NCBI]
|
7.23545e-06
|
|
|
THC1
|
[NCBI]
|
7.19845e-06
|
|
|
MRXS13
|
[NCBI]
|
7.19845e-06
|
|
|
encephalopathy, neonatal severe, due to mecp2 mutations
|
[NCBI]
|
7.19845e-06
|
|
|
leiomyoma, hereditary multiple, of skin
|
[NCBI]
|
7.19845e-06
|
|
|
PMDS
|
[NCBI]
|
7.19845e-06
|
|
|
apolipoprotein c-ii deficiency
|
[NCBI]
|
7.19845e-06
|
|
|
RHS
|
[NCBI]
|
7.19845e-06
|
|
|
medulloblastoma
|
[NCBI]
|
7.19845e-06
|
|
|
DFNA6
|
[NCBI]
|
7.19845e-06
|
|
|
SACS
|
[NCBI]
|
7.19845e-06
|
|
|
plasminogen deficiency, type i
|
[NCBI]
|
7.19845e-06
|
|
|
ALUNC
|
[NCBI]
|
7.19845e-06
|
|
|
myotonia congenita, autosomal recessive
|
[NCBI]
|
7.19845e-06
|
|
|
methylmalonic aciduria and homocystinuria, cblc type
|
[NCBI]
|
7.19845e-06
|
|
|
congenital cataracts, facial dysmorphism, and neuropathy
|
[NCBI]
|
7.19845e-06
|
|
|
PPD2
|
[NCBI]
|
7.19845e-06
|
|
|
CMT2B
|
[NCBI]
|
7.19845e-06
|
|
|
lipoid proteinosis of urbach and wiethe
|
[NCBI]
|
7.19845e-06
|
|
|
SLC6A4
|
[NCBI]
|
7.19725e-06
|
|
|
NBS1
|
[NCBI]
|
7.06777e-06
|
|
|
IKBKG
|
[NCBI]
|
7.06777e-06
|
|
|
CBD
|
[NCBI]
|
7.06777e-06
|
|
|
GCKR
|
[NCBI]
|
7.02246e-06
|
|
|
ST7
|
[NCBI]
|
7.02246e-06
|
|
|
CYP3A7
|
[NCBI]
|
7.02246e-06
|
|
|
SACS
|
[NCBI]
|
7.02246e-06
|
|
|
NUMBL
|
[NCBI]
|
7.02246e-06
|
|
|
TBCE
|
[NCBI]
|
7.02246e-06
|
|
|
BCKDHB
|
[NCBI]
|
7.02246e-06
|
|
|
ARSE
|
[NCBI]
|
7.02246e-06
|
|
|
MKKS
|
[NCBI]
|
7.02246e-06
|
|
|
IL21R
|
[NCBI]
|
7.02246e-06
|
|
|
PTF1A
|
[NCBI]
|
7.02246e-06
|
|
|
HCF2
|
[NCBI]
|
7.02246e-06
|
|
|
RFNG
|
[NCBI]
|
7.02246e-06
|
|
|
ABCG8
|
[NCBI]
|
7.02246e-06
|
|
|
TFAM
|
[NCBI]
|
7.02246e-06
|
|
|
KRT12
|
[NCBI]
|
7.02246e-06
|
|
|
CD9
|
[NCBI]
|
7.02246e-06
|
|
|
TICAM2
|
[NCBI]
|
7.02246e-06
|
|
|
OPHN1
|
[NCBI]
|
7.02246e-06
|
|
|
CDC2L1
|
[NCBI]
|
7.02246e-06
|
|
|
DNASE1
|
[NCBI]
|
7.02246e-06
|
|
|
KCNH2
|
[NCBI]
|
6.9238e-06
|
|
|
FHIT
|
[NCBI]
|
6.82245e-06
|
|
|
OA1
|
[NCBI]
|
6.82245e-06
|
|
|
LRP1
|
[NCBI]
|
6.81795e-06
|
|
|
PTEN
|
[NCBI]
|
6.78567e-06
|
|
|
MKS1
|
[NCBI]
|
6.66132e-06
|
|
|
FBN1
|
[NCBI]
|
6.60808e-06
|
|
|
ACP1
|
[NCBI]
|
6.58633e-06
|
|
|
PHEX
|
[NCBI]
|
6.58633e-06
|
|
|
PTHR1
|
[NCBI]
|
6.58633e-06
|
|
|
GATA1
|
[NCBI]
|
6.58633e-06
|
|
|
urogenital adysplasia, hereditary
|
[NCBI]
|
6.54561e-06
|
|
|
FSHR
|
[NCBI]
|
6.48544e-06
|
|
|
WAS
|
[NCBI]
|
6.47728e-06
|
|
|
HPD
|
[NCBI]
|
6.45003e-06
|
|
|
KCNJ6
|
[NCBI]
|
6.45003e-06
|
|
|
RP1
|
[NCBI]
|
6.45003e-06
|
|
|
AGC1
|
[NCBI]
|
6.45003e-06
|
|
|
IL2RB
|
[NCBI]
|
6.45003e-06
|
|
|
PLCB3
|
[NCBI]
|
6.45003e-06
|
|
|
flaujeac factor deficiency
|
[NCBI]
|
6.45003e-06
|
|
|
CR2
|
[NCBI]
|
6.45003e-06
|
|
|
HTRA1
|
[NCBI]
|
6.45003e-06
|
|
|
AIP
|
[NCBI]
|
6.45003e-06
|
|
|
DSG4
|
[NCBI]
|
6.45003e-06
|
|
|
KRT2A
|
[NCBI]
|
6.45003e-06
|
|
|
SCNN1G
|
[NCBI]
|
6.45003e-06
|
|
|
GBE1
|
[NCBI]
|
6.45003e-06
|
|
|
LDB3
|
[NCBI]
|
6.45003e-06
|
|
|
ANXA7
|
[NCBI]
|
6.45003e-06
|
|
|
LEFTY2
|
[NCBI]
|
6.45003e-06
|
|
|
SYCP3
|
[NCBI]
|
6.45003e-06
|
|
|
RECQL4
|
[NCBI]
|
6.45003e-06
|
|
|
HAL
|
[NCBI]
|
6.45003e-06
|
|
|
ITGA5
|
[NCBI]
|
6.45003e-06
|
|
|
AKT2
|
[NCBI]
|
6.45003e-06
|
|
|
CYP2E
|
[NCBI]
|
6.45003e-06
|
|
|
CDH13
|
[NCBI]
|
6.45003e-06
|
|
|
SHC1
|
[NCBI]
|
6.45003e-06
|
|
|
ALMS1
|
[NCBI]
|
6.45003e-06
|
|
|
PABPN1
|
[NCBI]
|
6.45003e-06
|
|
|
ANKH
|
[NCBI]
|
6.45003e-06
|
|
|
NCAM1
|
[NCBI]
|
6.45003e-06
|
|
|
CHEK1
|
[NCBI]
|
6.45003e-06
|
|
|
SOS1
|
[NCBI]
|
6.45003e-06
|
|
|
EVA
|
[NCBI]
|
6.42581e-06
|
|
|
myoclonic dystonia
|
[NCBI]
|
6.42581e-06
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
6.42581e-06
|
|
|
ALDH2
|
[NCBI]
|
6.3589e-06
|
|
|
ASPA
|
[NCBI]
|
6.3589e-06
|
|
|
GK
|
[NCBI]
|
6.3589e-06
|
|
|
PAX6
|
[NCBI]
|
6.18612e-06
|
|
|
ARH
|
[NCBI]
|
6.17685e-06
|
|
|
ACCPN
|
[NCBI]
|
6.17685e-06
|
|
|
adrenal hyperplasia, congenital, due to steroid 11-beta-hydroxylase deficiency
|
[NCBI]
|
6.17685e-06
|
|
|
amyloidosis v
|
[NCBI]
|
6.17685e-06
|
|
|
OPPG
|
[NCBI]
|
6.17685e-06
|
|
|
galactose epimerase deficiency
|
[NCBI]
|
6.17685e-06
|
|
|
bartter syndrome, antenatal, type 2
|
[NCBI]
|
6.17685e-06
|
|
|
KFSD
|
[NCBI]
|
6.17685e-06
|
|
|
MCDS
|
[NCBI]
|
6.17685e-06
|
|
|
LDS
|
[NCBI]
|
6.17685e-06
|
|
|
adult syndrome
|
[NCBI]
|
6.17685e-06
|
|
|
epidermolysis bullosa simplex and limb-girdle muscular dystrophy
|
[NCBI]
|
6.17685e-06
|
|
|
AEZ
|
[NCBI]
|
6.17685e-06
|
|
|
amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 1
|
[NCBI]
|
6.17685e-06
|
|
|
COL1A1
|
[NCBI]
|
6.13997e-06
|
|
|
RS1
|
[NCBI]
|
6.13973e-06
|
|
|
PDE6B
|
[NCBI]
|
6.13973e-06
|
|
|
OPTN
|
[NCBI]
|
6.13973e-06
|
|
|
PJS
|
[NCBI]
|
6.05029e-06
|
|
|
NEUROD1
|
[NCBI]
|
5.94408e-06
|
|
|
GYS1
|
[NCBI]
|
5.94408e-06
|
|
|
FACL4
|
[NCBI]
|
5.94408e-06
|
|
|
RORC
|
[NCBI]
|
5.94408e-06
|
|
|
T
|
[NCBI]
|
5.94408e-06
|
|
|
NPPB
|
[NCBI]
|
5.94408e-06
|
|
|
SGCG
|
[NCBI]
|
5.94408e-06
|
|
|
CYLD1
|
[NCBI]
|
5.94408e-06
|
|
|
NRXN1
|
[NCBI]
|
5.94408e-06
|
|
|
FGD1
|
[NCBI]
|
5.94408e-06
|
|
|
HOXA13
|
[NCBI]
|
5.94408e-06
|
|
|
STXBP1
|
[NCBI]
|
5.94408e-06
|
|
|
ALPI
|
[NCBI]
|
5.94408e-06
|
|
|
SECISBP2
|
[NCBI]
|
5.94408e-06
|
|
|
RPA1
|
[NCBI]
|
5.94408e-06
|
|
|
COL5A2
|
[NCBI]
|
5.94408e-06
|
|
|
BARD1
|
[NCBI]
|
5.94408e-06
|
|
|
KRT16
|
[NCBI]
|
5.94408e-06
|
|
|
POT1
|
[NCBI]
|
5.94408e-06
|
|
|
AAAS
|
[NCBI]
|
5.94408e-06
|
|
|
NR2E3
|
[NCBI]
|
5.94408e-06
|
|
|
MXI1
|
[NCBI]
|
5.94408e-06
|
|
|
C1QA
|
[NCBI]
|
5.94408e-06
|
|
|
MDH1
|
[NCBI]
|
5.94408e-06
|
|
|
PKLR
|
[NCBI]
|
5.92838e-06
|
|
|
GAMT
|
[NCBI]
|
5.92838e-06
|
|
|
SLC1A2
|
[NCBI]
|
5.92838e-06
|
|
|
AGTR1
|
[NCBI]
|
5.92838e-06
|
|
|
NOD2
|
[NCBI]
|
5.92838e-06
|
|
|
C4B
|
[NCBI]
|
5.92838e-06
|
|
|
RYR1
|
[NCBI]
|
5.89933e-06
|
|
|
CDPX2
|
[NCBI]
|
5.87907e-06
|
|
|
XLP1
|
[NCBI]
|
5.87907e-06
|
|
|
MM
|
[NCBI]
|
5.87907e-06
|
|
|
TBS
|
[NCBI]
|
5.87907e-06
|
|
|
BDNF
|
[NCBI]
|
5.87525e-06
|
|
|
SMS
|
[NCBI]
|
5.79522e-06
|
|
|
TNFRSF1B
|
[NCBI]
|
5.72448e-06
|
|
|
EDN1
|
[NCBI]
|
5.72448e-06
|
|
|
fucosidosis
|
[NCBI]
|
5.72448e-06
|
|
|
HP
|
[NCBI]
|
5.65264e-06
|
|
|
PDHA1
|
[NCBI]
|
5.52767e-06
|
|
|
HIF1A
|
[NCBI]
|
5.52767e-06
|
|
|
H19
|
[NCBI]
|
5.52767e-06
|
|
|
KRT17
|
[NCBI]
|
5.49247e-06
|
|
|
TFAP2B
|
[NCBI]
|
5.49247e-06
|
|
|
tritanopia
|
[NCBI]
|
5.49247e-06
|
|
|
ZIC3
|
[NCBI]
|
5.49247e-06
|
|
|
HPS1
|
[NCBI]
|
5.49247e-06
|
|
|
IVL
|
[NCBI]
|
5.49247e-06
|
|
|
SCN8A
|
[NCBI]
|
5.49247e-06
|
|
|
COL4A4
|
[NCBI]
|
5.49247e-06
|
|
|
SOAT1
|
[NCBI]
|
5.49247e-06
|
|
|
ITPA
|
[NCBI]
|
5.49247e-06
|
|
|
TIMM8A
|
[NCBI]
|
5.49247e-06
|
|
|
CXORF5
|
[NCBI]
|
5.49247e-06
|
|
|
FMN
|
[NCBI]
|
5.49247e-06
|
|
|
XRCC5
|
[NCBI]
|
5.49247e-06
|
|
|
PITX3
|
[NCBI]
|
5.49247e-06
|
|
|
loc387715 gene
|
[NCBI]
|
5.49247e-06
|
|
|
DGUOK
|
[NCBI]
|
5.49247e-06
|
|
|
CALR
|
[NCBI]
|
5.49247e-06
|
|
|
CCNA2
|
[NCBI]
|
5.49247e-06
|
|
|
FUT3
|
[NCBI]
|
5.49247e-06
|
|
|
UBQLN1
|
[NCBI]
|
5.49247e-06
|
|
|
ERAF
|
[NCBI]
|
5.49247e-06
|
|
|
RAB7
|
[NCBI]
|
5.49247e-06
|
|
|
RYR3
|
[NCBI]
|
5.49247e-06
|
|
|
TTPA
|
[NCBI]
|
5.49247e-06
|
|
|
SMARCA4
|
[NCBI]
|
5.49247e-06
|
|
|
ZNF9
|
[NCBI]
|
5.49247e-06
|
|
|
MS4A2
|
[NCBI]
|
5.49247e-06
|
|
|
MERTK
|
[NCBI]
|
5.49247e-06
|
|
|
PON2
|
[NCBI]
|
5.49247e-06
|
|
|
CES
|
[NCBI]
|
5.46786e-06
|
|
|
prostate cancer
|
[NCBI]
|
5.4457e-06
|
|
|
PEDF
|
[NCBI]
|
5.37801e-06
|
|
|
WFS1
|
[NCBI]
|
5.36705e-06
|
|
|
TFR2
|
[NCBI]
|
5.3376e-06
|
|
|
PCOS1
|
[NCBI]
|
5.32763e-06
|
|
|
mucopolysaccharidosis type iiic
|
[NCBI]
|
5.2841e-06
|
|
|
SCZD9
|
[NCBI]
|
5.2841e-06
|
|
|
anemia, dyserythropoietic congenital, type i
|
[NCBI]
|
5.2841e-06
|
|
|
NFNS
|
[NCBI]
|
5.2841e-06
|
|
|
USH1C
|
[NCBI]
|
5.2841e-06
|
|
|
CFEOM1
|
[NCBI]
|
5.2841e-06
|
|
|
SGD
|
[NCBI]
|
5.2841e-06
|
|
|
methionine adenosyltransferase deficiency
|
[NCBI]
|
5.2841e-06
|
|
|
GCCD1
|
[NCBI]
|
5.2841e-06
|
|
|
mitochondrial dna depletion syndrome, hepatocerebral form
|
[NCBI]
|
5.2841e-06
|
|
|
JLNS1
|
[NCBI]
|
5.2841e-06
|
|
|
cerebrotendinous xanthomatosis
|
[NCBI]
|
5.2841e-06
|
|
|
PPS
|
[NCBI]
|
5.2841e-06
|
|
|
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1
|
[NCBI]
|
5.2841e-06
|
|
|
HMN5
|
[NCBI]
|
5.2841e-06
|
|
|
disorganization, mouse, homolog of
|
[NCBI]
|
5.2841e-06
|
|
|
kaposi sarcoma
|
[NCBI]
|
5.2841e-06
|
|
|
langer mesomelic dysplasia
|
[NCBI]
|
5.2841e-06
|
|
|
GLA
|
[NCBI]
|
5.15398e-06
|
|
|
SCN4A
|
[NCBI]
|
5.15398e-06
|
|
|
BRAF
|
[NCBI]
|
5.15398e-06
|
|
|
MTHFR
|
[NCBI]
|
5.10804e-06
|
|
|
ESD
|
[NCBI]
|
5.08761e-06
|
|
|
GDF11
|
[NCBI]
|
5.08609e-06
|
|
|
OTX2
|
[NCBI]
|
5.08609e-06
|
|
|
PRKAG2
|
[NCBI]
|
5.08609e-06
|
|
|
ADD1
|
[NCBI]
|
5.08609e-06
|
|
|
SIRT2
|
[NCBI]
|
5.08609e-06
|
|
|
plasmin inhibitor deficiency
|
[NCBI]
|
5.08609e-06
|
|
|
CLCN7
|
[NCBI]
|
5.08609e-06
|
|
|
FCGR2B
|
[NCBI]
|
5.08609e-06
|
|
|
ID3
|
[NCBI]
|
5.08609e-06
|
|
|
PTPN6
|
[NCBI]
|
5.08609e-06
|
|
|
KRT8
|
[NCBI]
|
5.08609e-06
|
|
|
OCRL
|
[NCBI]
|
5.08609e-06
|
|
|
XBP1
|
[NCBI]
|
5.08609e-06
|
|
|
MEF2C
|
[NCBI]
|
5.08609e-06
|
|
|
DYRK1A
|
[NCBI]
|
5.08609e-06
|
|
|
diphosphoglycerate mutase deficiency of erythrocyte
|
[NCBI]
|
5.08609e-06
|
|
|
ZAP70
|
[NCBI]
|
5.08609e-06
|
|
|
EMX2
|
[NCBI]
|
5.08609e-06
|
|
|
SOX3
|
[NCBI]
|
5.08609e-06
|
|
|
OPMD
|
[NCBI]
|
5.06286e-06
|
|
|
ATS
|
[NCBI]
|
4.88778e-06
|
|
|
ASS
|
[NCBI]
|
4.86546e-06
|
|
|
HOS
|
[NCBI]
|
4.85226e-06
|
|
|
PNMT
|
[NCBI]
|
4.76253e-06
|
|
|
TD1
|
[NCBI]
|
4.72429e-06
|
|
|
DAZL
|
[NCBI]
|
4.71798e-06
|
|
|
GARS
|
[NCBI]
|
4.71798e-06
|
|
|
FLI1
|
[NCBI]
|
4.71798e-06
|
|
|
CD82
|
[NCBI]
|
4.71798e-06
|
|
|
SKI
|
[NCBI]
|
4.71798e-06
|
|
|
RASSF1
|
[NCBI]
|
4.71798e-06
|
|
|
PVRL1
|
[NCBI]
|
4.71798e-06
|
|
|
MTP
|
[NCBI]
|
4.71798e-06
|
|
|
HLA-C
|
[NCBI]
|
4.71798e-06
|
|
|
CDK5R1
|
[NCBI]
|
4.71798e-06
|
|
|
ACAT1
|
[NCBI]
|
4.71798e-06
|
|
|
FCGR2A
|
[NCBI]
|
4.71798e-06
|
|
|
RGS2
|
[NCBI]
|
4.71798e-06
|
|
|
CEP290
|
[NCBI]
|
4.71798e-06
|
|
|
FYN
|
[NCBI]
|
4.71798e-06
|
|
|
NCF2
|
[NCBI]
|
4.71798e-06
|
|
|
OLR1
|
[NCBI]
|
4.71798e-06
|
|
|
SRA2
|
[NCBI]
|
4.71798e-06
|
|
|
HLCS
|
[NCBI]
|
4.71798e-06
|
|
|
MYF6
|
[NCBI]
|
4.71798e-06
|
|
|
BLMH
|
[NCBI]
|
4.71798e-06
|
|
|
COL9A1
|
[NCBI]
|
4.71798e-06
|
|
|
MBD2
|
[NCBI]
|
4.71798e-06
|
|
|
PRPS1
|
[NCBI]
|
4.71798e-06
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
4.63895e-06
|
|
|
ARMD1
|
[NCBI]
|
4.55346e-06
|
|
|
hypophosphatasia, adult type
|
[NCBI]
|
4.50174e-06
|
|
|
lipoid congenital adrenal hyperplasia
|
[NCBI]
|
4.50174e-06
|
|
|
tibial muscular dystrophy, tardive
|
[NCBI]
|
4.50174e-06
|
|
|
gilbert syndrome
|
[NCBI]
|
4.50174e-06
|
|
|
MCPH1
|
[NCBI]
|
4.50174e-06
|
|
|
myasthenic syndrome, congenital, associated with episodic apnea
|
[NCBI]
|
4.50174e-06
|
|
|
LMS
|
[NCBI]
|
4.50174e-06
|
|
|
CRS1
|
[NCBI]
|
4.50174e-06
|
|
|
LGMD2B
|
[NCBI]
|
4.50174e-06
|
|
|
leprosy, susceptibility to
|
[NCBI]
|
4.50174e-06
|
|
|
alpha-thalassemia/mental retardation syndrome, deletion-type
|
[NCBI]
|
4.50174e-06
|
|
|
lymphedema-distichiasis syndrome
|
[NCBI]
|
4.50174e-06
|
|
|
waardenburg-shah syndrome
|
[NCBI]
|
4.50174e-06
|
|
|
potocki-shaffer syndrome
|
[NCBI]
|
4.50174e-06
|
|
|
CFTD
|
[NCBI]
|
4.50174e-06
|
|
|
holocarboxylase synthetase deficiency
|
[NCBI]
|
4.50174e-06
|
|
|
MTS
|
[NCBI]
|
4.50174e-06
|
|
|
omenn syndrome
|
[NCBI]
|
4.50174e-06
|
|
|
CHNG1
|
[NCBI]
|
4.50174e-06
|
|
|
SOST
|
[NCBI]
|
4.50174e-06
|
|
|
HMS1
|
[NCBI]
|
4.50174e-06
|
|
|
L1CAM
|
[NCBI]
|
4.47838e-06
|
|
|
DCT
|
[NCBI]
|
4.47838e-06
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
4.43948e-06
|
|
|
aHUS
|
[NCBI]
|
4.43948e-06
|
|
|
PDS
|
[NCBI]
|
4.43948e-06
|
|
|
CTNS
|
[NCBI]
|
4.43948e-06
|
|
|
mucolipidosis ii
|
[NCBI]
|
4.43948e-06
|
|
|
PLG
|
[NCBI]
|
4.395e-06
|
|
|
PRH1
|
[NCBI]
|
4.38265e-06
|
|
|
RHAG
|
[NCBI]
|
4.38265e-06
|
|
|
PRX
|
[NCBI]
|
4.38265e-06
|
|
|
LU
|
[NCBI]
|
4.38265e-06
|
|
|
HABP2
|
[NCBI]
|
4.38265e-06
|
|
|
NDN
|
[NCBI]
|
4.38265e-06
|
|
|
CD14
|
[NCBI]
|
4.38265e-06
|
|
|
DVL1
|
[NCBI]
|
4.38265e-06
|
|
|
TECTA
|
[NCBI]
|
4.38265e-06
|
|
|
POLH
|
[NCBI]
|
4.38265e-06
|
|
|
RNR1
|
[NCBI]
|
4.38265e-06
|
|
|
HTATIP
|
[NCBI]
|
4.38265e-06
|
|
|
AGTR2
|
[NCBI]
|
4.38265e-06
|
|
|
P2RX7
|
[NCBI]
|
4.38265e-06
|
|
|
NEFH
|
[NCBI]
|
4.38265e-06
|
|
|
ALAD
|
[NCBI]
|
4.32298e-06
|
|
|
BPES
|
[NCBI]
|
4.26095e-06
|
|
|
SHFM1
|
[NCBI]
|
4.25389e-06
|
|
|
AKT1
|
[NCBI]
|
4.17253e-06
|
|
|
COL3A1
|
[NCBI]
|
4.17253e-06
|
|
|
NTRK1
|
[NCBI]
|
4.17253e-06
|
|
|
MSTN
|
[NCBI]
|
4.17253e-06
|
|
|
PRF1
|
[NCBI]
|
4.17253e-06
|
|
|
COL2A1
|
[NCBI]
|
4.09057e-06
|
|
|
KCNQ2
|
[NCBI]
|
4.07571e-06
|
|
|
GGCX
|
[NCBI]
|
4.07571e-06
|
|
|
CTNS
|
[NCBI]
|
4.07571e-06
|
|
|
TAP1
|
[NCBI]
|
4.07571e-06
|
|
|
SDHB
|
[NCBI]
|
4.07571e-06
|
|
|
NAGLU
|
[NCBI]
|
4.07571e-06
|
|
|
CNP
|
[NCBI]
|
4.07571e-06
|
|
|
LIG4
|
[NCBI]
|
4.07571e-06
|
|
|
APOA4
|
[NCBI]
|
4.07571e-06
|
|
|
MHC2TA
|
[NCBI]
|
4.07571e-06
|
|
|
SPG3A
|
[NCBI]
|
4.07571e-06
|
|
|
SGSH
|
[NCBI]
|
4.07571e-06
|
|
|
HEPH
|
[NCBI]
|
4.07571e-06
|
|
|
TP73
|
[NCBI]
|
4.07571e-06
|
|
|
C4BPA
|
[NCBI]
|
4.07571e-06
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
4.06869e-06
|
|
|
NP
|
[NCBI]
|
4.02685e-06
|
|
|
CACNA1A
|
[NCBI]
|
4.02685e-06
|
|
|
HHF1
|
[NCBI]
|
4.02049e-06
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
3.97495e-06
|
|
|
MAP1B
|
[NCBI]
|
3.88575e-06
|
|
|
PFM
|
[NCBI]
|
3.81502e-06
|
|
|
PFIC1
|
[NCBI]
|
3.81502e-06
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
3.81502e-06
|
|
|
CMDD
|
[NCBI]
|
3.81502e-06
|
|
|
GCE
|
[NCBI]
|
3.81502e-06
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
3.81502e-06
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
3.81502e-06
|
|
|
exostoses, multiple, type ii
|
[NCBI]
|
3.81502e-06
|
|
|
hartnup disorder
|
[NCBI]
|
3.81502e-06
|
|
|
hurler-scheie syndrome
|
[NCBI]
|
3.81502e-06
|
|
|
AFD1
|
[NCBI]
|
3.81502e-06
|
|
|
BMPR1A
|
[NCBI]
|
3.79362e-06
|
|
|
PANK2
|
[NCBI]
|
3.79362e-06
|
|
|
AMY2A
|
[NCBI]
|
3.79362e-06
|
|
|
PRKCA
|
[NCBI]
|
3.79362e-06
|
|
|
SGCA
|
[NCBI]
|
3.79362e-06
|
|
|
FLG
|
[NCBI]
|
3.79362e-06
|
|
|
LRAT
|
[NCBI]
|
3.79362e-06
|
|
|
LAMA2
|
[NCBI]
|
3.79362e-06
|
|
|
TERF1
|
[NCBI]
|
3.79362e-06
|
|
|
PLIN
|
[NCBI]
|
3.79362e-06
|
|
|
NCF1
|
[NCBI]
|
3.79362e-06
|
|
|
COL18A1
|
[NCBI]
|
3.79362e-06
|
|
|
MC3R
|
[NCBI]
|
3.79362e-06
|
|
|
ADRB1
|
[NCBI]
|
3.79362e-06
|
|
|
EIF2C2
|
[NCBI]
|
3.79362e-06
|
|
|
LYST
|
[NCBI]
|
3.79362e-06
|
|
|
TLR1
|
[NCBI]
|
3.79362e-06
|
|
|
BEST1
|
[NCBI]
|
3.79362e-06
|
|
|
CEBPA
|
[NCBI]
|
3.79362e-06
|
|
|
CD99
|
[NCBI]
|
3.79362e-06
|
|
|
SCN9A
|
[NCBI]
|
3.79362e-06
|
|
|
VIL2
|
[NCBI]
|
3.79362e-06
|
|
|
KEAP1
|
[NCBI]
|
3.79362e-06
|
|
|
HFM
|
[NCBI]
|
3.78936e-06
|
|
|
RIPK1
|
[NCBI]
|
3.74904e-06
|
|
|
CYP2D6
|
[NCBI]
|
3.74904e-06
|
|
|
CDK5
|
[NCBI]
|
3.63642e-06
|
|
|
GALT
|
[NCBI]
|
3.61658e-06
|
|
|
RLBP1
|
[NCBI]
|
3.61658e-06
|
|
|
SLC45A2
|
[NCBI]
|
3.53344e-06
|
|
|
CRX
|
[NCBI]
|
3.53344e-06
|
|
|
SMAD3
|
[NCBI]
|
3.53344e-06
|
|
|
EN1
|
[NCBI]
|
3.53344e-06
|
|
|
NR5A2
|
[NCBI]
|
3.53344e-06
|
|
|
DLL3
|
[NCBI]
|
3.53344e-06
|
|
|
CSH1
|
[NCBI]
|
3.53344e-06
|
|
|
WNT1
|
[NCBI]
|
3.53344e-06
|
|
|
C7
|
[NCBI]
|
3.53344e-06
|
|
|
PAX1
|
[NCBI]
|
3.53344e-06
|
|
|
SOX2
|
[NCBI]
|
3.53344e-06
|
|
|
DLL1
|
[NCBI]
|
3.53344e-06
|
|
|
GABRG2
|
[NCBI]
|
3.53344e-06
|
|
|
CCR2
|
[NCBI]
|
3.53344e-06
|
|
|
KLF5
|
[NCBI]
|
3.53344e-06
|
|
|
GNB3
|
[NCBI]
|
3.53344e-06
|
|
|
NSD1
|
[NCBI]
|
3.53344e-06
|
|
|
SERPINA6
|
[NCBI]
|
3.50224e-06
|
|
|
ABL1
|
[NCBI]
|
3.4882e-06
|
|
|
PON1
|
[NCBI]
|
3.40624e-06
|
|
|
WHS
|
[NCBI]
|
3.35371e-06
|
|
|
CD
|
[NCBI]
|
3.35371e-06
|
|
|
TFPI
|
[NCBI]
|
3.32486e-06
|
|
|
hypertelorism with esophageal abnormality and hypospadias
|
[NCBI]
|
3.31682e-06
|
|
|
PEE1
|
[NCBI]
|
3.31682e-06
|
|
|
PFKM
|
[NCBI]
|
3.29274e-06
|
|
|
GJA3
|
[NCBI]
|
3.29274e-06
|
|
|
CBP
|
[NCBI]
|
3.29274e-06
|
|
|
SREBF1
|
[NCBI]
|
3.29274e-06
|
|
|
TSHB
|
[NCBI]
|
3.29274e-06
|
|
|
MAPK8IP1
|
[NCBI]
|
3.29274e-06
|
|
|
F2RL1
|
[NCBI]
|
3.29274e-06
|
|
|
GLUD1
|
[NCBI]
|
3.29274e-06
|
|
|
SQSTM1
|
[NCBI]
|
3.29274e-06
|
|
|
ACTA1
|
[NCBI]
|
3.29274e-06
|
|
|
Ge
|
[NCBI]
|
3.29274e-06
|
|
|
USH1C
|
[NCBI]
|
3.29274e-06
|
|
|
TCF3
|
[NCBI]
|
3.29274e-06
|
|
|
EPOR
|
[NCBI]
|
3.28845e-06
|
|
|
RSTS
|
[NCBI]
|
3.26446e-06
|
|
|
C3
|
[NCBI]
|
3.24311e-06
|
|
|
LBR
|
[NCBI]
|
3.24311e-06
|
|
|
SLC2A4
|
[NCBI]
|
3.22037e-06
|
|
|
MKKS
|
[NCBI]
|
3.21196e-06
|
|
|
refsum disease
|
[NCBI]
|
3.21196e-06
|
|
|
diabetes-deafness syndrome, maternally transmitted
|
[NCBI]
|
3.21196e-06
|
|
|
alkaptonuria
|
[NCBI]
|
3.21196e-06
|
|
|
pituitary dwarfism iii
|
[NCBI]
|
3.21196e-06
|
|
|
SPCH1
|
[NCBI]
|
3.21196e-06
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
3.21196e-06
|
|
|
diarrhea 1, secretory chloride, congenital
|
[NCBI]
|
3.21196e-06
|
|
|
EEC3
|
[NCBI]
|
3.21196e-06
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
3.21196e-06
|
|
|
SCCMS
|
[NCBI]
|
3.21196e-06
|
|
|
crigler-najjar syndrome
|
[NCBI]
|
3.21196e-06
|
|
|
IL6
|
[NCBI]
|
3.16752e-06
|
|
|
PSEN2
|
[NCBI]
|
3.12613e-06
|
|
|
ADA
|
[NCBI]
|
3.08383e-06
|
|
|
ERCC3
|
[NCBI]
|
3.06946e-06
|
|
|
G6PT1
|
[NCBI]
|
3.06946e-06
|
|
|
CSF1R
|
[NCBI]
|
3.06946e-06
|
|
|
SGCE
|
[NCBI]
|
3.06946e-06
|
|
|
KCNJ2
|
[NCBI]
|
3.06946e-06
|
|
|
FRAXE
|
[NCBI]
|
3.06946e-06
|
|
|
LMX1B
|
[NCBI]
|
3.06946e-06
|
|
|
SPR
|
[NCBI]
|
3.06946e-06
|
|
|
COL11A2
|
[NCBI]
|
3.06946e-06
|
|
|
FGF3
|
[NCBI]
|
3.06946e-06
|
|
|
FLT4
|
[NCBI]
|
3.06946e-06
|
|
|
PRKCG
|
[NCBI]
|
3.06946e-06
|
|
|
KRIT1
|
[NCBI]
|
3.06946e-06
|
|
|
PCDH15
|
[NCBI]
|
3.06946e-06
|
|
|
TNFRSF13B
|
[NCBI]
|
3.06946e-06
|
|
|
TKT
|
[NCBI]
|
3.06946e-06
|
|
|
TERF2
|
[NCBI]
|
3.06946e-06
|
|
|
KCNE1
|
[NCBI]
|
3.06946e-06
|
|
|
ECM1
|
[NCBI]
|
3.06946e-06
|
|
|
CHS
|
[NCBI]
|
2.94594e-06
|
|
|
CLS
|
[NCBI]
|
2.90114e-06
|
|
|
BCR
|
[NCBI]
|
2.89752e-06
|
|
|
ZS
|
[NCBI]
|
2.87222e-06
|
|
|
CHRNA4
|
[NCBI]
|
2.86185e-06
|
|
|
EPB41
|
[NCBI]
|
2.86185e-06
|
|
|
DMBT1
|
[NCBI]
|
2.86185e-06
|
|
|
NNMT
|
[NCBI]
|
2.86185e-06
|
|
|
DBT
|
[NCBI]
|
2.86185e-06
|
|
|
NEU1
|
[NCBI]
|
2.86185e-06
|
|
|
WNK1
|
[NCBI]
|
2.86185e-06
|
|
|
AMELX
|
[NCBI]
|
2.86185e-06
|
|
|
ERCC6
|
[NCBI]
|
2.86185e-06
|
|
|
DLL4
|
[NCBI]
|
2.86185e-06
|
|
|
PGD
|
[NCBI]
|
2.86185e-06
|
|
|
VDR
|
[NCBI]
|
2.85277e-06
|
|
|
ABCB1
|
[NCBI]
|
2.80424e-06
|
|
|
CDH1
|
[NCBI]
|
2.79594e-06
|
|
|
IGF1
|
[NCBI]
|
2.79594e-06
|
|
|
PGR
|
[NCBI]
|
2.76561e-06
|
|
|
WT1
|
[NCBI]
|
2.69242e-06
|
|
|
EA2
|
[NCBI]
|
2.68271e-06
|
|
|
FHM2
|
[NCBI]
|
2.68271e-06
|
|
|
SHEP2
|
[NCBI]
|
2.68271e-06
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
2.68271e-06
|
|
|
bladder cancer
|
[NCBI]
|
2.68271e-06
|
|
|
pituitary dwarfism i
|
[NCBI]
|
2.68271e-06
|
|
|
HAMP
|
[NCBI]
|
2.66843e-06
|
|
|
CHRNA1
|
[NCBI]
|
2.66843e-06
|
|
|
CTSD
|
[NCBI]
|
2.66843e-06
|
|
|
CR1
|
[NCBI]
|
2.66843e-06
|
|
|
DCX
|
[NCBI]
|
2.66843e-06
|
|
|
PEX7
|
[NCBI]
|
2.66843e-06
|
|
|
TBX5
|
[NCBI]
|
2.66843e-06
|
|
|
CLCN5
|
[NCBI]
|
2.66843e-06
|
|
|
SLC2A1
|
[NCBI]
|
2.66843e-06
|
|
|
AGER
|
[NCBI]
|
2.65233e-06
|
|
|
STAT1
|
[NCBI]
|
2.65233e-06
|
|
|
BGLAP
|
[NCBI]
|
2.65233e-06
|
|
|
ITGB3
|
[NCBI]
|
2.592e-06
|
|
|
CYP19A1
|
[NCBI]
|
2.49458e-06
|
|
|
CASP3
|
[NCBI]
|
2.4879e-06
|
|
|
GHSR
|
[NCBI]
|
2.4879e-06
|
|
|
DBH
|
[NCBI]
|
2.4879e-06
|
|
|
DKC1
|
[NCBI]
|
2.4879e-06
|
|
|
KRT1
|
[NCBI]
|
2.4879e-06
|
|
|
PIK3CA
|
[NCBI]
|
2.4879e-06
|
|
|
GATA4
|
[NCBI]
|
2.4879e-06
|
|
|
CYP27B1
|
[NCBI]
|
2.4879e-06
|
|
|
EBP
|
[NCBI]
|
2.4879e-06
|
|
|
CBX5
|
[NCBI]
|
2.45353e-06
|
|
|
NF2
|
[NCBI]
|
2.41029e-06
|
|
|
TF
|
[NCBI]
|
2.34713e-06
|
|
|
FOS
|
[NCBI]
|
2.31914e-06
|
|
|
CASP8
|
[NCBI]
|
2.31914e-06
|
|
|
NRTN
|
[NCBI]
|
2.31914e-06
|
|
|
MRE11A
|
[NCBI]
|
2.31914e-06
|
|
|
SLC5A7
|
[NCBI]
|
2.31914e-06
|
|
|
TCOF1
|
[NCBI]
|
2.31914e-06
|
|
|
APTX
|
[NCBI]
|
2.31914e-06
|
|
|
LCK
|
[NCBI]
|
2.31914e-06
|
|
|
RPE65
|
[NCBI]
|
2.31914e-06
|
|
|
CA1
|
[NCBI]
|
2.31914e-06
|
|
|
ABL
|
[NCBI]
|
2.31569e-06
|
|
|
EDMD
|
[NCBI]
|
2.31569e-06
|
|
|
JAK3
|
[NCBI]
|
2.30837e-06
|
|
|
CPI
|
[NCBI]
|
2.3019e-06
|
|
|
CD36
|
[NCBI]
|
2.2194e-06
|
|
|
HRPT1
|
[NCBI]
|
2.21904e-06
|
|
|
BFLS
|
[NCBI]
|
2.21904e-06
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
2.21904e-06
|
|
|
HIDS
|
[NCBI]
|
2.21904e-06
|
|
|
JBS
|
[NCBI]
|
2.21904e-06
|
|
|
BRRS
|
[NCBI]
|
2.17749e-06
|
|
|
HSR
|
[NCBI]
|
2.16117e-06
|
|
|
IRF1
|
[NCBI]
|
2.16117e-06
|
|
|
LDHA
|
[NCBI]
|
2.16117e-06
|
|
|
MFN2
|
[NCBI]
|
2.16117e-06
|
|
|
COL4A1
|
[NCBI]
|
2.16117e-06
|
|
|
CYP11B1
|
[NCBI]
|
2.16117e-06
|
|
|
CASP1
|
[NCBI]
|
2.16117e-06
|
|
|
ACE
|
[NCBI]
|
2.15205e-06
|
|
|
OMP
|
[NCBI]
|
2.11663e-06
|
|
|
DDC
|
[NCBI]
|
2.11663e-06
|
|
|
TNC
|
[NCBI]
|
2.06971e-06
|
|
|
CTNNB1
|
[NCBI]
|
2.04935e-06
|
|
|
INS
|
[NCBI]
|
2.0461e-06
|
|
|
SCS
|
[NCBI]
|
2.04425e-06
|
|
|
MMP1
|
[NCBI]
|
2.01312e-06
|
|
|
EGR2
|
[NCBI]
|
2.01312e-06
|
|
|
FKRP
|
[NCBI]
|
2.01312e-06
|
|
|
AQP5
|
[NCBI]
|
2.01312e-06
|
|
|
TGM1
|
[NCBI]
|
2.01312e-06
|
|
|
LRP5
|
[NCBI]
|
2.01312e-06
|
|
|
NKX2E
|
[NCBI]
|
2.01312e-06
|
|
|
SLC12A3
|
[NCBI]
|
2.01312e-06
|
|
|
CMT1B
|
[NCBI]
|
1.95358e-06
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
1.95358e-06
|
|
|
JAK2
|
[NCBI]
|
1.9527e-06
|
|
|
ESR1
|
[NCBI]
|
1.94843e-06
|
|
|
CD59
|
[NCBI]
|
1.87423e-06
|
|
|
GLO1
|
[NCBI]
|
1.87423e-06
|
|
|
LDHB
|
[NCBI]
|
1.87423e-06
|
|
|
FGF4
|
[NCBI]
|
1.87423e-06
|
|
|
LYZ
|
[NCBI]
|
1.87423e-06
|
|
|
BMP15
|
[NCBI]
|
1.87423e-06
|
|
|
ELA2
|
[NCBI]
|
1.87423e-06
|
|
|
MAPK7
|
[NCBI]
|
1.87423e-06
|
|
|
SP7
|
[NCBI]
|
1.87423e-06
|
|
|
MAG
|
[NCBI]
|
1.85857e-06
|
|
|
canavan disease
|
[NCBI]
|
1.81405e-06
|
|
|
HEPOD
|
[NCBI]
|
1.81405e-06
|
|
|
AAA
|
[NCBI]
|
1.81405e-06
|
|
|
PLOSL
|
[NCBI]
|
1.81405e-06
|
|
|
MSS
|
[NCBI]
|
1.81405e-06
|
|
|
MODY
|
[NCBI]
|
1.74677e-06
|
|
|
MLP
|
[NCBI]
|
1.74382e-06
|
|
|
SLC22A5
|
[NCBI]
|
1.74382e-06
|
|
|
CTSK
|
[NCBI]
|
1.74382e-06
|
|
|
GSTM1
|
[NCBI]
|
1.74382e-06
|
|
|
CD4
|
[NCBI]
|
1.74382e-06
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
1.73895e-06
|
|
|
SCA6
|
[NCBI]
|
1.73895e-06
|
|
|
LWD
|
[NCBI]
|
1.73895e-06
|
|
|
MITF
|
[NCBI]
|
1.70608e-06
|
|
|
SLC17A7
|
[NCBI]
|
1.62129e-06
|
|
|
AICDA
|
[NCBI]
|
1.62129e-06
|
|
|
CHRNE
|
[NCBI]
|
1.62129e-06
|
|
|
GJA8
|
[NCBI]
|
1.62129e-06
|
|
|
MYCN
|
[NCBI]
|
1.62129e-06
|
|
|
contractural arachnodactyly, congenital
|
[NCBI]
|
1.62129e-06
|
|
|
CD8A
|
[NCBI]
|
1.62129e-06
|
|
|
KL
|
[NCBI]
|
1.62129e-06
|
|
|
CCND1
|
[NCBI]
|
1.61862e-06
|
|
|
SPINK1
|
[NCBI]
|
1.57544e-06
|
|
|
sotos syndrome
|
[NCBI]
|
1.53401e-06
|
|
|
ALGS1
|
[NCBI]
|
1.53401e-06
|
|
|
LFNG
|
[NCBI]
|
1.50609e-06
|
|
|
SPTB
|
[NCBI]
|
1.50609e-06
|
|
|
SLC25A4
|
[NCBI]
|
1.50609e-06
|
|
|
TNFRSF10A
|
[NCBI]
|
1.50609e-06
|
|
|
SLC22A6
|
[NCBI]
|
1.50609e-06
|
|
|
KRT14
|
[NCBI]
|
1.50609e-06
|
|
|
SMA1
|
[NCBI]
|
1.47132e-06
|
|
|
CDKN2A
|
[NCBI]
|
1.46217e-06
|
|
|
MNGIE
|
[NCBI]
|
1.46187e-06
|
|
|
CDPX1
|
[NCBI]
|
1.46187e-06
|
|
|
UCMD
|
[NCBI]
|
1.46187e-06
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
1.46187e-06
|
|
|
SCA17
|
[NCBI]
|
1.46187e-06
|
|
|
GJB1
|
[NCBI]
|
1.44814e-06
|
|
|
TTN
|
[NCBI]
|
1.39773e-06
|
|
|
GP1BA
|
[NCBI]
|
1.39773e-06
|
|
|
ADK
|
[NCBI]
|
1.39773e-06
|
|
|
CMH
|
[NCBI]
|
1.35548e-06
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
1.35067e-06
|
|
|
ADH5
|
[NCBI]
|
1.29578e-06
|
|
|
complement component 6 deficiency
|
[NCBI]
|
1.29578e-06
|
|
|
APOH
|
[NCBI]
|
1.29578e-06
|
|
|
TGFBR2
|
[NCBI]
|
1.29578e-06
|
|
|
NCOA3
|
[NCBI]
|
1.29578e-06
|
|
|
DPYD
|
[NCBI]
|
1.29578e-06
|
|
|
GCDH
|
[NCBI]
|
1.29578e-06
|
|
|
EKD1
|
[NCBI]
|
1.25836e-06
|
|
|
CAPN3
|
[NCBI]
|
1.19982e-06
|
|
|
ALDH3A2
|
[NCBI]
|
1.19982e-06
|
|
|
IL1A
|
[NCBI]
|
1.19982e-06
|
|
|
EIG
|
[NCBI]
|
1.19956e-06
|
|
|
MTR
|
[NCBI]
|
1.16516e-06
|
|
|
mucopolysaccharidosis type vi
|
[NCBI]
|
1.15745e-06
|
|
|
MDC1A
|
[NCBI]
|
1.15745e-06
|
|
|
mucolipidosis iv
|
[NCBI]
|
1.15745e-06
|
|
|
aortic aneurysm, abdominal
|
[NCBI]
|
1.15745e-06
|
|
|
pulmonary fibrosis, idiopathic
|
[NCBI]
|
1.15745e-06
|
|
|
epidermolysis bullosa with pyloric atresia
|
[NCBI]
|
1.15745e-06
|
|
|
HNPP
|
[NCBI]
|
1.15689e-06
|
|
|
sickle cell anemia
|
[NCBI]
|
1.15689e-06
|
|
|
RTS
|
[NCBI]
|
1.15499e-06
|
|
|
LI1
|
[NCBI]
|
1.15499e-06
|
|
|
KRT5
|
[NCBI]
|
1.1095e-06
|
|
|
HLA-B
|
[NCBI]
|
1.1095e-06
|
|
|
FASN
|
[NCBI]
|
1.1095e-06
|
|
|
oca2 gene
|
[NCBI]
|
1.1095e-06
|
|
|
CXCL12
|
[NCBI]
|
1.1095e-06
|
|
|
MN
|
[NCBI]
|
1.1095e-06
|
|
|
MAOA
|
[NCBI]
|
1.08808e-06
|
|
|
PCI
|
[NCBI]
|
1.05024e-06
|
|
|
DNMT3B
|
[NCBI]
|
1.02449e-06
|
|
|
HDAC1
|
[NCBI]
|
1.01287e-06
|
|
|
GJA1
|
[NCBI]
|
9.87619e-07
|
|
|
HAE
|
[NCBI]
|
9.81887e-07
|
|
|
HSAN3
|
[NCBI]
|
9.81887e-07
|
|
|
FCMD
|
[NCBI]
|
9.8051e-07
|
|
|
NRG1
|
[NCBI]
|
9.75966e-07
|
|
|
CREM
|
[NCBI]
|
9.44479e-07
|
|
|
CDK6
|
[NCBI]
|
9.44479e-07
|
|
|
FABP3
|
[NCBI]
|
9.44479e-07
|
|
|
GSN
|
[NCBI]
|
9.44479e-07
|
|
|
RHO
|
[NCBI]
|
9.11834e-07
|
|
|
MS
|
[NCBI]
|
9.1114e-07
|
|
|
PG
|
[NCBI]
|
9.03605e-07
|
|
|
PIGR
|
[NCBI]
|
9.03605e-07
|
|
|
MSD
|
[NCBI]
|
8.96447e-07
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
8.96447e-07
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
8.96447e-07
|
|
|
CYP2A6
|
[NCBI]
|
8.69191e-07
|
|
|
IL13
|
[NCBI]
|
8.69191e-07
|
|
|
IGKC
|
[NCBI]
|
8.69191e-07
|
|
|
COMT
|
[NCBI]
|
8.68519e-07
|
|
|
PSORS1
|
[NCBI]
|
8.24395e-07
|
|
|
IGER
|
[NCBI]
|
8.20431e-07
|
|
|
FGF10
|
[NCBI]
|
7.98373e-07
|
|
|
MDM2
|
[NCBI]
|
7.98373e-07
|
|
|
PRPH2
|
[NCBI]
|
7.98373e-07
|
|
|
NTRK2
|
[NCBI]
|
7.98373e-07
|
|
|
CDK4
|
[NCBI]
|
7.80219e-07
|
|
|
UCP1
|
[NCBI]
|
7.74216e-07
|
|
|
APOC2
|
[NCBI]
|
7.31788e-07
|
|
|
RAG1
|
[NCBI]
|
7.31788e-07
|
|
|
ATP7A
|
[NCBI]
|
7.31788e-07
|
|
|
SLC26A4
|
[NCBI]
|
7.31788e-07
|
|
|
myopathy, myofibrillar, desmin-related
|
[NCBI]
|
6.75091e-07
|
|
|
CMM2
|
[NCBI]
|
6.75091e-07
|
|
|
biotinidase deficiency
|
[NCBI]
|
6.75091e-07
|
|
|
alcohol dependence
|
[NCBI]
|
6.75091e-07
|
|
|
glycogen storage disease ib
|
[NCBI]
|
6.75091e-07
|
|
|
POAG
|
[NCBI]
|
6.71203e-07
|
|
|
MTS
|
[NCBI]
|
6.71203e-07
|
|
|
FOP
|
[NCBI]
|
6.71203e-07
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
6.71203e-07
|
|
|
SMEI
|
[NCBI]
|
6.71203e-07
|
|
|
GRIA2
|
[NCBI]
|
6.69218e-07
|
|
|
SHOX
|
[NCBI]
|
6.69218e-07
|
|
|
MICA
|
[NCBI]
|
6.69218e-07
|
|
|
JAG1
|
[NCBI]
|
6.69218e-07
|
|
|
PEMT
|
[NCBI]
|
6.69218e-07
|
|
|
IL4
|
[NCBI]
|
6.66485e-07
|
|
|
PTGS2
|
[NCBI]
|
6.34794e-07
|
|
|
PAEP
|
[NCBI]
|
6.34794e-07
|
|
|
PPT1
|
[NCBI]
|
6.10465e-07
|
|
|
APP
|
[NCBI]
|
6.06495e-07
|
|
|
LEPR
|
[NCBI]
|
5.73156e-07
|
|
|
ABCG2
|
[NCBI]
|
5.60145e-07
|
|
|
SMN2
|
[NCBI]
|
5.5534e-07
|
|
|
CUTL1
|
[NCBI]
|
5.5534e-07
|
|
|
GRN
|
[NCBI]
|
5.5534e-07
|
|
|
ALB
|
[NCBI]
|
5.44176e-07
|
|
|
BTHS
|
[NCBI]
|
5.34832e-07
|
|
|
melanoma, uveal
|
[NCBI]
|
5.34832e-07
|
|
|
CSF2
|
[NCBI]
|
5.03672e-07
|
|
|
charge syndrome
|
[NCBI]
|
4.90071e-07
|
|
|
MHA
|
[NCBI]
|
4.90071e-07
|
|
|
thiourea tasting
|
[NCBI]
|
4.90071e-07
|
|
|
MELAS
|
[NCBI]
|
4.90071e-07
|
|
|
MRXHF1
|
[NCBI]
|
4.90071e-07
|
|
|
AMH
|
[NCBI]
|
4.83043e-07
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
4.57197e-07
|
|
|
CTLA4
|
[NCBI]
|
4.55299e-07
|
|
|
SEMA3A
|
[NCBI]
|
4.55299e-07
|
|
|
FOLH1
|
[NCBI]
|
4.55299e-07
|
|
|
HLA-DRA
|
[NCBI]
|
4.55299e-07
|
|
|
HNF1A
|
[NCBI]
|
4.29806e-07
|
|
|
HYPP
|
[NCBI]
|
4.11992e-07
|
|
|
ADIPOQ
|
[NCBI]
|
4.10072e-07
|
|
|
LEP
|
[NCBI]
|
3.94338e-07
|
|
|
TERT
|
[NCBI]
|
3.72776e-07
|
|
|
PRLR
|
[NCBI]
|
3.67924e-07
|
|
|
ENG
|
[NCBI]
|
3.67851e-07
|
|
|
SOX9
|
[NCBI]
|
3.67851e-07
|
|
|
DGS
|
[NCBI]
|
3.60366e-07
|
|
|
DYX1
|
[NCBI]
|
3.3848e-07
|
|
|
dyschromatosis symmetrica hereditaria 1
|
[NCBI]
|
3.3848e-07
|
|
|
SMA2
|
[NCBI]
|
3.3848e-07
|
|
|
osteoarthritis
|
[NCBI]
|
3.3848e-07
|
|
|
ALMS
|
[NCBI]
|
3.3848e-07
|
|
|
SLS
|
[NCBI]
|
3.36578e-07
|
|
|
C4A
|
[NCBI]
|
3.28504e-07
|
|
|
KAL1
|
[NCBI]
|
3.28504e-07
|
|
|
SCD
|
[NCBI]
|
3.16856e-07
|
|
|
PLTP
|
[NCBI]
|
3.15248e-07
|
|
|
neuraminidase deficiency
|
[NCBI]
|
3.03417e-07
|
|
|
COH1
|
[NCBI]
|
3.03417e-07
|
|
|
lactase persistence
|
[NCBI]
|
3.03417e-07
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
3.03417e-07
|
|
|
VIM
|
[NCBI]
|
2.92983e-07
|
|
|
LCT
|
[NCBI]
|
2.79978e-07
|
|
|
MJD
|
[NCBI]
|
2.7394e-07
|
|
|
PLN
|
[NCBI]
|
2.57572e-07
|
|
|
CLU
|
[NCBI]
|
2.35943e-07
|
|
|
ENPP2
|
[NCBI]
|
2.26531e-07
|
|
|
CD47
|
[NCBI]
|
2.26531e-07
|
|
|
OPTB1
|
[NCBI]
|
2.17744e-07
|
|
|
OKS
|
[NCBI]
|
2.17744e-07
|
|
|
OPA1
|
[NCBI]
|
2.09897e-07
|
|
|
MDLS
|
[NCBI]
|
2.09897e-07
|
|
|
AANAT
|
[NCBI]
|
1.97536e-07
|
|
|
MLL
|
[NCBI]
|
1.97536e-07
|
|
|
STC1
|
[NCBI]
|
1.75905e-07
|
|
|
TPO
|
[NCBI]
|
1.71665e-07
|
|
|
HRG
|
[NCBI]
|
1.57574e-07
|
|
|
isoniazid inactivation
|
[NCBI]
|
1.46457e-07
|
|
|
ALS1
|
[NCBI]
|
1.4315e-07
|
|
|
asthma, susceptibility to
|
[NCBI]
|
1.4315e-07
|
|
|
CLL
|
[NCBI]
|
1.32294e-07
|
|
|
walker-warburg syndrome
|
[NCBI]
|
1.32294e-07
|
|
|
SJS1
|
[NCBI]
|
1.32294e-07
|
|
|
PCTT
|
[NCBI]
|
1.32294e-07
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
1.25577e-07
|
|
|
DAR
|
[NCBI]
|
1.25577e-07
|
|
|
neural tube defects
|
[NCBI]
|
1.25577e-07
|
|
|
HSAS
|
[NCBI]
|
1.25577e-07
|
|
|
IGHG1
|
[NCBI]
|
1.24199e-07
|
|
|
MTTL1
|
[NCBI]
|
1.23556e-07
|
|
|
MECP2
|
[NCBI]
|
1.21523e-07
|
|
|
AGT
|
[NCBI]
|
1.04021e-07
|
|
|
B2M
|
[NCBI]
|
1.04021e-07
|
|
|
FLNA
|
[NCBI]
|
1.04021e-07
|
|
|
RTT
|
[NCBI]
|
9.96719e-08
|
|
|
DNMT1
|
[NCBI]
|
9.54803e-08
|
|
|
SLC18A2
|
[NCBI]
|
6.96039e-08
|
|
|
INSL3
|
[NCBI]
|
6.96039e-08
|
|
|
SHH
|
[NCBI]
|
6.02923e-08
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
5.9937e-08
|
|
|
testicular tumors
|
[NCBI]
|
5.9937e-08
|
|
|
pyruvate decarboxylase deficiency
|
[NCBI]
|
5.9937e-08
|
|
|
alzheimer disease 3
|
[NCBI]
|
5.9937e-08
|
|
|
leiomyomatosis and renal cell cancer, hereditary
|
[NCBI]
|
5.9937e-08
|
|
|
HPS
|
[NCBI]
|
5.71659e-08
|
|
|
GDNF
|
[NCBI]
|
5.69911e-08
|
|
|
A2M
|
[NCBI]
|
5.52262e-08
|
|
|
NR0B2
|
[NCBI]
|
4.43268e-08
|
|
|
THRB
|
[NCBI]
|
4.43268e-08
|
|
|
VCP
|
[NCBI]
|
4.43268e-08
|
|
|
COMP
|
[NCBI]
|
3.78891e-08
|
|
|
DRD4
|
[NCBI]
|
3.4717e-08
|
|
|
PCD
|
[NCBI]
|
2.90956e-08
|
|
|
UBTF
|
[NCBI]
|
2.62091e-08
|
|
|
IL10
|
[NCBI]
|
2.62091e-08
|
|
|
IHH
|
[NCBI]
|
2.25733e-08
|
|
|
NRCLP1
|
[NCBI]
|
1.89951e-08
|
|
|
graves disease
|
[NCBI]
|
1.89951e-08
|
|
|
AQP2
|
[NCBI]
|
1.88336e-08
|
|
|
SOD2
|
[NCBI]
|
1.83216e-08
|
|
|
PGK1
|
[NCBI]
|
1.51225e-08
|
|
|
ASL
|
[NCBI]
|
1.51225e-08
|
|
|
SLC11A1
|
[NCBI]
|
1.51225e-08
|
|
|
TFF3
|
[NCBI]
|
1.26224e-08
|
|
|
CP
|
[NCBI]
|
1.12612e-08
|
|
|
KRAS
|
[NCBI]
|
9.1652e-09
|
|
|
AQP4
|
[NCBI]
|
9.1652e-09
|
|
|
KLF1
|
[NCBI]
|
9.1652e-09
|
|
|
GSC
|
[NCBI]
|
9.1652e-09
|
|
|
HRAS
|
[NCBI]
|
9.1652e-09
|
|
|
gastric cancer
|
[NCBI]
|
4.77611e-09
|
|
|
SCA1
|
[NCBI]
|
3.72919e-09
|
|
|
FGFR1
|
[NCBI]
|
2.62982e-09
|
|
|
porphyria variegata
|
[NCBI]
|
2.20872e-09
|
|
|
CHH
|
[NCBI]
|
2.20872e-09
|
|
|
LIPC
|
[NCBI]
|
1.31455e-09
|
|
|
NOTCH1
|
[NCBI]
|
1.31455e-09
|
|
|
exostoses, multiple, type i
|
[NCBI]
|
1.10388e-09
|
|
|
RBS
|
[NCBI]
|
1.10388e-09
|
|
|
SPARC
|
[NCBI]
|
1.08024e-10
|
|
|
ELN
|
[NCBI]
|
1.08024e-10
|
|